<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000160.pub2" GROUP_ID="STROKE" ID="907499073011534743" MERGED_FROM="" MODIFIED="2009-08-03 17:15:17 +0200" MODIFIED_BY="Hazel Fraser" REVIEW_NO="0002" REVMAN_SUB_VERSION="5.0.21" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2009-08-03 17:15:17 +0200" MODIFIED_BY="Hazel Fraser">
<TITLE>Patch angioplasty versus primary closure for carotid endarterectomy</TITLE>
<CONTACT MODIFIED="2009-08-03 17:15:17 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="16532" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Rothwell</LAST_NAME><EMAIL_1>peter.rothwell@clneuro.ox.ac.uk</EMAIL_1><URL>www.stroke.ox.ac.uk</URL><ADDRESS><DEPARTMENT>Stroke Prevention Research Unit, Department of Clinical Neurology</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>Level 6, West Wing, John Radcliffe Hospital</ADDRESS_1><ADDRESS_2>Headington</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX3 9DU</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 617158</PHONE_1><FAX_1>+44 1865 617161</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-08-03 17:15:17 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="17162" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Kittipan</FIRST_NAME><LAST_NAME>Rerkasem</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><EMAIL_1>krerkase@mail.med.cmu.ac.th</EMAIL_1><MOBILE_PHONE>+66 858668484</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Surgery, Faculty of Medicine</DEPARTMENT><ORGANISATION>Chiang Mai University</ORGANISATION><CITY>Chiang Mai</CITY><ZIP>50200</ZIP><COUNTRY CODE="TH">Thailand</COUNTRY><PHONE_1>+66 053 94 5532</PHONE_1><FAX_1>+66 053 946139</FAX_1></ADDRESS></PERSON><PERSON ID="16532" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Rothwell</LAST_NAME><EMAIL_1>peter.rothwell@clneuro.ox.ac.uk</EMAIL_1><URL>www.stroke.ox.ac.uk</URL><ADDRESS><DEPARTMENT>Stroke Prevention Research Unit, Department of Clinical Neurology</DEPARTMENT><ORGANISATION>University of Oxford</ORGANISATION><ADDRESS_1>Level 6, West Wing, John Radcliffe Hospital</ADDRESS_1><ADDRESS_2>Headington</ADDRESS_2><CITY>Oxford</CITY><ZIP>OX3 9DU</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1865 617158</PHONE_1><FAX_1>+44 1865 617161</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-07-20 11:26:48 +0100" MODIFIED_BY="Hazel Fraser">
<UP_TO_DATE>
<DATE DAY="5" MONTH="5" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="11" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="8" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1996"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="1996"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="1995"/>
</DATES>
<WHATS_NEW MODIFIED="2009-07-20 11:29:21 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-07-20 11:27:06 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="5" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>The searches have been completed to November 2008. In the four years since the previous version of this Cochrane Review was published, there have been two new randomised trials and we also added a trial published in 1986 which was not identified in the previous review. The new trials included data on 750 operations and 17 stroke/death outcomes. The conclusion of this updated review is more conservative than that in the previous review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2009-07-20 11:29:21 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="5" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>The authorship of the review has changed. The conclusion of the review has changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-07-20 11:28:23 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-20 11:28:23 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="9" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-09-09 21:09:17 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="2" YEAR="2003"/>
<DESCRIPTION>
<P>Differences between this review and the previous version: one new trial (357 patients and 399 operations), comparing primary closure with venous patching (saphenous or jugular vein) and with synthetic patching, has published its early and late results (AbuRahma 1996 and 1998) and has been included in the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-08-03 16:06:56 +0100" MODIFIED_BY="Hazel Fraser">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Oxford University Medical Research Fund (MRF)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2009-08-03 16:06:56 +0100" MODIFIED_BY="Hazel Fraser">
<SOURCE>
<NAME>Medical Research Council</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2009-08-03 16:06:56 +0100" MODIFIED_BY="Hazel Fraser">
<NAME>Chiang Mai University</NAME>
<COUNTRY CODE="TH">Thailand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>NHS Executive Research and Development Directorate</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-07-31 13:55:41 +0100" MODIFIED_BY="Hazel Fraser">
<SUMMARY MODIFIED="2009-07-20 11:35:05 +0100" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2008-09-09 20:21:05 +0100" MODIFIED_BY="[Empty name]">Patch angioplasty versus primary closure for carotid endarterectomy</TITLE>
<SUMMARY_BODY MODIFIED="2009-07-20 11:35:05 +0100" MODIFIED_BY="Hazel Fraser">
<P>Evidence from this review of 10 trials involving 1967 patients undergoing 2157 operations now suggests a benefit from using routine patch angioplasty during carotid endarterectomy. About 20% of strokes result from narrowing of the carotid artery (the main artery supplying blood to the brain). Carotid endarterectomy is an operation that involves opening the carotid artery to remove this narrowing and, therefore, reduce the risk of stroke. However, there is a 2% to 10% risk of the operation itself causing a stroke. Some surgeons advocate the incorporation of a patch made out of either synthetic material or the patient's own vein, into the arterial closure. This may help to reduce the risk of the artery being narrowed during suture placement and may, therefore, reduce the risk of recurrent blockage and consequent stroke or death or both. However, use of a patch may increase surgical difficulty and operation length. Furthermore, thin-walled vein patches may rupture with potentially fatal consequences and synthetic materials are vulnerable to infection.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-07-20 15:21:23 +0100" MODIFIED_BY="Hazel Fraser">
<ABS_BACKGROUND MODIFIED="2009-07-20 15:20:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>Carotid patch angioplasty (with either a venous or a synthetic patch) may reduce the risk of carotid artery restenosis and subsequent ischaemic stroke. This is an update of a Cochrane Review originally published in 1995 and previously updated in 2004.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2009-07-20 11:29:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>To assess the safety and efficacy of routine or selective carotid patch angioplasty compared to carotid endarterectomy with primary closure.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-07-20 15:21:23 +0100" MODIFIED_BY="Hazel Fraser">
<P>We searched the Cochrane Stroke Group Trials Register (last searched 5 May 2009), the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I>, Issue 1, 2009), MEDLINE (1966 to November 2008), EMBASE (1980 to November 2008) and Index to Scientific and Technical Proceedings (1980 to November 2008). We handsearched journals and conference proceedings, checked reference lists, and contacted experts in the field.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised and quasi-randomised trials comparing carotid patch angioplasty with primary closure in any patients undergoing carotid endarterectomy.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-07-20 11:30:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two review authors independently assessed eligibility, trial quality and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-07-20 11:31:48 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included 10 trials involving 1967 patients undergoing 2157 operations. The quality of trials was generally poor. Follow up varied from hospital discharge to five years. Carotid patch angioplasty was associated with a reduction in the risk of ipsilateral stroke during the perioperative period (odds ratio (OR) 0.31, 95% confidence interval (CI) 0.15 to 0.63, P = 0.001) and long-term follow up (OR 0.32, 95%CI 0.16 to 0.63, P = 0.001). It was also associated with a reduced risk of perioperative arterial occlusion (OR 0.18, 95% CI 0.08 to 0.41, P &lt; 0.0001), and decreased restenosis during long-term follow up in eight trials (OR 0.24, 95% CI 0.17 to 0.34, P &lt; 0.00001). These results are more certain than those of the previous review since the number of operations and events have increased. However, the sample sizes are still relatively small, data were not available from all trials, and there was significant loss to follow up. Very few arterial complications, including haemorrhage, infection, cranial nerve palsies and pseudo-aneurysm formation were recorded with either patch or primary closure. No significant correlation was found between use of patch angioplasty and the risk of either perioperative or long-term all-cause death rates.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-07-03 05:04:59 +0100" MODIFIED_BY="[Empty name]">
<P>Limited evidence suggests that carotid patch angioplasty may reduce the risk of perioperative arterial occlusion and restenosis. It would appear to reduce the risk of ipsilateral stroke and there is a non significant trend towards a reduction in perioperative any stroke rate and all-cause case fatality.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-07-31 13:55:41 +0100" MODIFIED_BY="Hazel Fraser">
<BACKGROUND MODIFIED="2009-07-20 15:23:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>Carotid endarterectomy has been shown in large, well-conducted randomised controlled trials to reduce the risk of stroke in patients with recently symptomatic, severe (greater than 70%) internal carotid artery stenosis (<LINK REF="REF-Rothwell-2003" TYPE="REFERENCE">Rothwell 2003</LINK>). There is also some evidence that it is beneficial for asymptomatic patients (<LINK REF="REF-ACAS-1995" TYPE="REFERENCE">ACAS 1995</LINK>; <LINK REF="REF-Halliday-2004" TYPE="REFERENCE">Halliday 2004</LINK>). What is less clear at present is whether different surgical techniques affect the outcome. One such technique is carotid patch angioplasty, with either a venous patch or a synthetic patch. Might this be as safe as primary closure, reduce the risk of restenosis and, more importantly, improve the long-term clinical outcome?</P>
<P>There are relatively few good prospective studies of restenosis following carotid endarterectomy and studies are difficult to compare because of differences in the definitions of stenosis and lengths of follow up. However, it appears that carotid restenosis of greater than 50% diameter reduction (as detected by Doppler ultrasound) occurs in 6% to 36% of patients during long-term follow up (<LINK REF="REF-Bernstein-1990" TYPE="REFERENCE">Bernstein 1990</LINK>; <LINK REF="REF-Knudsen-1990" TYPE="REFERENCE">Knudsen 1990</LINK>; <LINK REF="REF-Ouriel-1987" TYPE="REFERENCE">Ouriel 1987</LINK>; <LINK REF="REF-Volteas-1994" TYPE="REFERENCE">Volteas 1994</LINK>; <LINK REF="REF-Zierler-1982" TYPE="REFERENCE">Zierler 1982</LINK>). The majority of stenoses occur in the first two years (<LINK REF="REF-Frericks-1998" TYPE="REFERENCE">Frericks 1998</LINK>). Carotid patch angioplasty may reduce the risk of restenosis, and so reduce the long-term risk of recurrent ipsilateral ischaemic stroke (<LINK REF="REF-Awad-1989" TYPE="REFERENCE">Awad 1989</LINK>; <LINK REF="REF-Ouriel-1987" TYPE="REFERENCE">Ouriel 1987</LINK>). However, the risk of symptomatic restenosis appears to be much lower - about 2% to 4% (<LINK REF="REF-Das-1985" TYPE="REFERENCE">Das 1985</LINK>; <LINK REF="REF-Frericks-1998" TYPE="REFERENCE">Frericks 1998</LINK>), and patch angioplasty may also be associated with certain perioperative risks: routine patching involves a longer carotid occlusion time, two suture lines instead of one and the use of a patch material, all of which may increase the risk of early re-occlusion, arterial rupture, infection or pseudoaneurysm formation (<LINK REF="REF-Awad-1989" TYPE="REFERENCE">Awad 1989</LINK>; <LINK REF="REF-Bernstein-1992" TYPE="REFERENCE">Bernstein 1992</LINK>). In addition, if a venous patch is used, there may be morbidity associated with vein harvesting, such as neuralgia, haemorrhage, and infection.</P>
<P>A survey from the United Kingdom in a trial showed considerable variations among vascular surgeons in the use of carotid patching, which may reflect uncertainty in its benefits: 76% of surgeons always used patching, 19.4% sometimes and 4.6% never (<LINK REF="REF-Girn-2008" TYPE="REFERENCE">Girn 2008</LINK>). Analysis of the ECST trial data showed significant heterogeneity in frequency of use of patch angioplasty at an individual surgeon, national and international level (<LINK REF="REF-ECST-1991" TYPE="REFERENCE">ECST 1991</LINK>). Given the uncertainty implied by such variation in practice, it is clearly important to establish whether routine or selective patching is more effective than, and as safe as, primary closure. Randomised controlled trials provide the most reliable evidence on which to base these assessments. We, therefore, performed a systematic review of all such trials that compared routine or selective patching with primary closure.</P>
<P>NB: The first version of this review included trials comparing one type of patch with another. These trials have now been included in a separate Cochrane review (<LINK REF="REF-Bond-2003" TYPE="REFERENCE">Bond 2003</LINK>).</P>
<P>This is an update of a Cochrane Review originally published in 1995 and previously updated in 2004.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2009-07-20 11:39:50 +0100" MODIFIED_BY="Hazel Fraser">
<P>To assess the safety and efficacy of routine or selective carotid patch angioplasty with either a venous patch or a synthetic patch compared to primary closure. We wished to test the primary hypothesis that carotid patch angioplasty resulted in a lower rate of significant arterial restenosis and therefore fewer recurrent strokes and stroke-related deaths without a significant increase in perioperative complications.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-07-31 13:55:41 +0100" MODIFIED_BY="Hazel Fraser">
<SELECTION_CRITERIA MODIFIED="2009-07-20 11:42:27 +0100" MODIFIED_BY="Hazel Fraser">
<CRIT_STUDIES MODIFIED="2009-07-20 11:40:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>We sought to identify all unconfounded randomised trials of carotid patching. We included quasi-randomised trials in which allocation to different treatment regimens was not adequately concealed (e.g. allocation by alternation, date of birth, hospital number, day of the week, or by using an open random number list), but foreknowledge of treatment allocation might lead to biased treatment allocation and exaggerated treatment effects (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2009-07-20 11:40:44 +0100" MODIFIED_BY="Hazel Fraser">
<P>We considered trials that included any type of patient undergoing carotid endarterectomy as eligible, whether the initial indication for endarterectomy was symptomatic or asymptomatic carotid disease.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>We sought to identify all trials comparing routine carotid patch angioplasty (i.e. patching attempted in all patients) with primary closure. Any type of patch material was eligible e.g. venous, Dacron, or polytetrafluoroethylene (PTFE). We also intended to include trials comparing selective patch angioplasty (i.e. patching attempted only in patients thought likely to benefit) with primary closure, but we failed to identify any such trials. Trials which compared one type of patch with another are included in a separate Cochrane review (<LINK REF="REF-Bond-2003" TYPE="REFERENCE">Bond 2003</LINK>).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2009-07-20 11:42:27 +0100" MODIFIED_BY="Hazel Fraser">
<P>We aimed to extract from each trial the number of patients originally allocated to each treatment group to allow an intention-to-treat analysis. Within each treatment group we then extracted the number of patients:</P>
<OL>
<LI>who died within 30 days of the operation and during subsequent follow up. We tried to classify each death as stroke-related or not;</LI>
<LI>who had any stroke within 30 days of the operation and during subsequent follow up. A separate analysis of strokes ipsilateral to the endarterectomy was also performed;</LI>
<LI>who had known occlusion of the artery that was operated on within 30 days of the operation;</LI>
<LI>who had a significant complication related to surgery, such as haemorrhage from or rupture of the artery, infection of the endarterectomy site, cranial nerve palsy or pseudoaneurysm formation;</LI>
<LI>who developed restenosis greater than 50% or occlusion of the artery that was operated on during follow up.</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-07-31 13:55:02 +0100" MODIFIED_BY="Hazel Fraser">
<P>See the 'Specialized register' section in the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/STROKE/frame.html">Cochrane Stroke Group</A> module.</P>
<P>We searched the Cochrane Stroke Group trials register, which was last searched by the Managing Editor in May 2009. We also updated the electronic searches and handsearched additional issues of relevant journals as follows.</P>
<OL>
<LI>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I>, Issue 1, 2009); MEDLINE (1966 to November 2008) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), EMBASE (1980 to November 2008) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), and Index to Scientific and Technical Proceedings (1980 to November 2008), which was searched using the terms "carotid" and ("trial* or random*").</LI>
<LI>We handsearched the following journals, including conference supplements:</LI>
<OL>
<LI>
<I>Annals of Surgery</I> (1981 to September 2008);</LI>
<LI>
<I>Annals of Vascular Surgery</I> (1994 to September 2008);</LI>
<LI>
<I>Cardiovascular Surgery</I> (now Vascular) (1994 to September 2008);</LI>
<LI>
<I>European Journal of Vascular Surgery</I> (now <I>European Journal of Vascular and Endovascular Surgery</I>) (1987 to September 2008);</LI>
<LI>
<I>Journal of Vascular Surgery</I> (1994 to September 2008);</LI>
<LI>
<I>Stroke</I> (1994 to September 2008).</LI>
</OL>
<LI>We reviewed the reference lists of all relevant studies.</LI>
<LI>We contacted experts in the field to identify further published and unpublished studies</LI>
<LI>For the previous version of the review:</LI>
<OL>
<LI>we hand-searched the following journals, including conference supplements:</LI>
<OL>
<LI>
<I>American Journal of Surgery </I>(1994 to 2001);</LI>
<LI>
<I>British Journal of Surgery </I>(1985 to 2001);</LI>
<LI>
<I>World Journal of Surgery</I> (1978 to 2001).</LI>
</OL>
<LI>we handsearched abstracts of the following meetings for the years 1995 to 2001:</LI>
<OL>
<LI>AGM of the Vascular Surgical Society (UK);</LI>
<LI>AGM of the Association of Surgeons of Great Britain and Ireland;</LI>
<LI>AHA Stroke Conference;</LI>
<LI>Annual Meeting of the Society for Vascular Surgery (USA);</LI>
<LI>European Stroke Conference.</LI>
</OL>
</OL>
</OL>
<P>We did not apply any language restriction in the searches and arranged translation of all possibly relevant non-English language publications.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-07-31 13:55:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>One review author (KR) selected those trials that met the inclusion criteria, and the other review author (PMR) independently reviewed these decisions. We resolved all disagreements through discussion.The same two review authors also assessed the methodological quality of each trial. We decided not to use a scoring system to assess quality but simply to record the following details: the randomisation method, the blinding of the clinical and Doppler assessments, whether outcomes were reported for all patients originally randomised in each group irrespective of whether they received the operation they were allocated to or whether the patient was excluded after randomisation, and the number of patients lost to follow up. We sought data on the number of outcome events in all patients originally randomised to allow an intention-to-treat analysis. We extracted and cross-checked all data. In addition, we also extracted details about the patients included in the trial, the inclusion and exclusion criteria, the comparability of the treatment and control groups for important prognostic factors, the type of patch, the type of anaesthetic, the use of shunts, and the use of antiplatelet therapy during follow up. If any of the above data were not available from the publication, we sought further information by correspondence with the trialists.</P>
<P>All of the trials included both patients who had unilateral carotid endaterectomies and patients who had bilateral carotid endarterectomies, and in most the artery was randomised to a particular procedure rather than the patient (<LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>; <LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>; <LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>). In these trials, it was therefore possible for one patient to have primary closure on one side and carotid patching on the other side. Indeed, in one trial if a patient required bilateral endarterectomies, each artery had to have a different procedure (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). In the reporting of these trials, the results were given for each artery that was randomised rather than for each individual patient. This makes sense for arterial complications such as haemorrhage or occlusion, for ipsilateral events, and for complication within 30 days of surgery (since most patients waited at least this period between the first and second operation), but it is not ideal for patient-related long-term clinical outcome events such as death or any stroke. In patients with bilateral endarterectomies who had both patching and primary closure, it would not be possible to relate death or stroke to one particular procedure. Therefore, In trials where it was possible for a patient to have both procedures, we analysed death and any stroke only in those who had unilateral procedures or the same procedure to both arteries. These data were available from the authors in all except two trials (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). In one trial, the investigators no longer had the original data on patients with unilateral operations and so this trial was excluded from the analyses of these outcomes (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>). In the other trial (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>), the number of patients undergoing unilateral endarterectomies was reported and we were able to estimate the number of clinical events per patient in each group using the number of events per artery and the total number of deaths that were reported.</P>
<P>A separate analysis of only strokes ipsilateral to the operated artery was also performed for each artery. However, this may be less useful as the more important outcome is the total number of strokes and not just the ipsilateral strokes. We analysed arterial complications, such as occlusion, haemorrhage from the endarterectomy site, restenosis, infection at the operation site, or pseudoaneurysm formation for all arteries rather than patients. The analyses based on arteries assumed that, in patients who had bilateral endarterectomies, outcome events in each carotid artery were independent. This is unlikely to be true but given that relatively few patients had bilateral procedures (10% overall) we felt it reasonable to perform such analyses. However, their results should be interpreted with caution.</P>
<P>About 40 patients were lost to follow up. For the intention-to-treat analyses, we assumed that patients who were lost to follow up did not have an outcome event. For the main analyses, we assumed that patients who were lost did not have an outcome event. In the previous version of this review, where statistically significant results were found, worst-case sensitivity analyses were performed to determine whether the results were robust. These analyses assumed that all patients lost from the patching arm had an adverse outcome, whereas none of those lost from the control arm did. However, for this review these analyses have not been included since the current authors consider them to be unreasonably critical.</P>
<P>We calculated proportional risk reductions based on a weighted estimate of the odds ratio using the Peto method (<LINK REF="REF-APT-1994" TYPE="REFERENCE">APT 1994</LINK>). Since all the outcome events assessed were rare, the odds ratios quoted will be similar to the relative risks. We calculated absolute risk reductions from the crude risks of each outcome in all trials combined (<LINK REF="REF-APT-1994" TYPE="REFERENCE">APT 1994</LINK>). We assessed heterogeneity between study results using the I<SUP>2 </SUP>statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). This examined the percentage of total variation across studies due to heterogeneity rather than to chance. Values of I<SUP>2 </SUP>over 75% indicate a high level of heterogeneity.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-07-20 12:25:03 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY_DESCRIPTION MODIFIED="2009-07-20 12:10:23 +0100" MODIFIED_BY="Hazel Fraser">
<P>Seven trials that fulfilled the eligibility criteria were identified by the 2004 version of this review, but only two new randomised controlled trials have been reported since then (<LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>). We also found one trial published in 1986 that was not identified in the previous verison of the review and it is included in this version (<LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>). We have not identified any additional ongoing trials, and there are no trials presently awaiting assessment. We excluded two trials: in one unpublished trial, an intention-to-treat analysis was not possible because one-third of the 300 patients randomised did not receive their allocated operation and results for these patients were not available (<LINK REF="STD-Gale-1985" TYPE="STUDY">Gale 1985</LINK>); in the discussion section of one of the published papers (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>), another unpublished trial was quoted but after discussion with the principal investigator, it became apparent that this trial was not in fact random or quasi-random (<LINK REF="STD-Hertzer-1987" TYPE="STUDY">Hertzer 1987</LINK>).</P>
<P>All of the trials we included compared routine patching with primary closure. Three of the trials used only saphenous vein patches (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>; <LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>), and three used synthetic patches (<LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>). Four trials used both vein and synthetic - PTFE or Dacron - patches (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>; <LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>), but in two of these (<LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>), results were not recorded by the type of patch that the patient received. In the previous review, the results of one of these trials (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>) were presented by splitting them into vein patching versus control and synthetic patching versus control. However, on hindsight, this was incorrect since it allowed the number of operations with primary closure to be counted twice in the overall analysis. Therefore, for the updated review we have analysed these three trials as any patch versus no patch.</P>
<P>One of the trials included a group that was allocated to obligate patching without randomisation (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). This group of patients was not included in the analyses. All operations were performed under general anaesthetic, and most were also performed with shunting. Most of the patients in all the trials received antiplatelet or anticoagulant drugs long term after the operation. All the trials with follow up beyond hospital discharge included Doppler ultrasound of the arteries during follow up, and one also included intravenous digital subtraction angiography (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>).</P>
<P>The average age of patients involved in these trials was about 67 years and there were approximately twice as many men as women. All of the trials included patients with asymptomatic carotid disease with the proportion varying from 8% (<LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>) to 51% (<LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>). All trials compared routine patching in all patients in the treatment group with primary closure. In four trials, narrow carotid arteries were excluded before randomisation on the basis that it was not safe to close these with primary closure: in one trial, 38 out of a total of 163 arteries were excluded because the internal diameter (assessed at operation) was less than 5 mm (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>); in one trial, one patient out of a possible 110 patients was excluded because the arterial diameter was less than 3.5 mm (assessed from the preoperative angiogram) (<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>); in one trial, 12 out of 399 carotid endarterectomies were excluded if internal carotid artery diameter was less than 4 mm (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>); and in one trial, 24 out of 422 were excluded if small diameter internal carotid artery or the need for an interposition graft. In the remaining trials, only one patient randomised to primary closure required a patch because the artery was felt to be too narrow (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>). Seven other patients randomised to primary closure required patching either because the stenosis was very high (two patients) or because the artery became occluded postoperatively (five patients). Seven patients from the patch group did not receive a patch either because no vein was available (two patients), because rapid closure was required due to possible ischaemic changes on an EEG during the operation (one patient), or for no apparent reason (four patients). The average follow up varied from hospital discharge (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>) to five years (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). In all trials in which the data were available, the treatment groups were comparable for important prognostic factors.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-07-20 12:13:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>There were several significant flaws in most of the trials. Firstly, allocation concealment was only adequate in six trials which used numbered, sealed, opaque, envelopes as the method of randomisation (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>). One study used envelope randomisation but they were not numbered or opaque (<LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>). Two trials used quasi-random allocation based on the patient's hospital number (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>) or social security number (<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>). Secondly, adequate blinding is important in order to reduce bias in the detection of certain outcome events. For instance, ultrasound assessment of restenosis should probably be assessed blind, although experienced practitioners may be able to detect the slight dilatation associated with a carotid patch even when blinded. Correspondence with the authors confirmed that clinical assessment was definitely blinded in only three trials (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>; <LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>), but that restenosis was assessed blind in all except two trials (<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>).</P>
<P>As mentioned previously, one of the main flaws in eight of the trials was that a patient undergoing bilateral carotid endarterectomy could be randomised twice and have their two carotid arteries randomised to different treatment groups (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>; <LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>; <LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>). In these trials, it was unclear from the published reports exactly how many patients (as opposed to arteries) were randomised to each group and how many patients with bilateral endarterectomies had different procedures to each artery (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). We were able to obtain these data from all except one trial (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>). Demographic features, such as age and sex, as well as results were usually reported for each randomised artery rather than per patient. True intention-to-treat analysis was only possible for three trials after we obtained additional data from the authors (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>). In the other trials, data on patients lost to follow up were not available, and in one trial four patients who did not have the procedure that they were randomised to receive were excluded from the analysis (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-07-20 12:25:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included data from 10 trials (1967 patients, 2157 operations) in this review. The results presented may differ from those in the published reports where additional information has been obtained from the authors. There was no statistical heterogeneity in any of the analyses.</P>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes within 30 days of operation</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Stroke</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Any stroke (fatal, non-fatal, contralateral, ipsilateral, brainstem, haemorrhage, or infarct)</HEADING>
<P>The overall perioperative risk of any stroke was 2.5% (45/1769). Patching was associated with a non-significant reduction in the odds of any stroke (odds ratio (OR) 0.57, 95% confidence interval (CI) 0.31 to 1.03, P = 0.06) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Within each closure type there was no heterogeneity, but there was significant between-group heterogeneity (I<SUP>2 </SUP>= 60.3). None of the trials recorded the severity of stroke in terms of residual disability, but only three of these strokes were fatal (one in the patch group, two in the primary closure group).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ipsilateral stroke (haemorrhage or infarct)</HEADING>
<P>If effective, patching would be expected to reduce mainly stroke ipsilateral to the operated artery. The number of ipsilateral strokes per artery randomised was available from seven trials, although in several instances we required additional data from the authors. No data were available from the three new trials. In total, 2.8% (33/1201) of operations were associated with an ipsilateral stroke. Carotid patching was associated with a statistically significant reduction in the relative odds of perioperative ipsilateral stroke (OR 0.31, 95% CI 0.15 to 0.63, P = 0.001) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Death</HEADING>
<P>There were only 11 deaths in the nine trials with available data (overall risk = 0.6%, 11/1869), and so it remains unclear whether patching is associated with a higher or lower perioperative mortality than primary closure (OR 0.62, 95% CI 0.18 to 2.09, P = 0.4) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Stroke or death</HEADING>
<P>Combined stroke/death rate was non-significantly lower in the patching group (OR 0.58, 95% CI 0.33 to 1.01, P = 0.06) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arterial complications</HEADING>
<P>As noted in the <LINK TAG="METHODS" TYPE="SECTION">Methods</LINK> section, these results should be interpreted with caution since, in patients who underwent bilateral endarterectomies, outcomes in each artery were probably not independent. We were unable to identify how many patients with bilateral endarterectomies had outcomes events in both arteries.</P>
<SUBSECTION>
<HEADING LEVEL="5">Arterial occlusion</HEADING>
<P>Three trials did not provide data on perioperative arterial occlusion (<LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>; <LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>; <LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>). Of the other trials, four used ultrasound (Duplex) scanning (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>; <LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>), two used intravenous digital subtraction angiography (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>; <LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>) and one used ocular pneumoplethysmography (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). At least 26 of the randomised arteries were not assessed within 30 days of operation (14 patch, 12 primary closure) and these arteries were assumed to be not occluded for the purpose of this analysis. Patching was associated with a highly statistically significant 82% reduction (OR 0.18 P &lt; 0.0001) in the odds of perioperative arterial occlusion. However, this result was based on small numbers (4/794 (0.5%) patching versus 20/641 (3.1%) primary closure) and so the confidence interval was wide (OR 0.18, 95% CI 0.08 to 0.41 P &lt; 0.0001) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). As documented above, however, the consequences to the patients (in terms of stroke-related death and non-fatal stroke) resulting from this reduction in arterial occlusion were unclear.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Arterial rupture/haemorrhage</HEADING>
<P>The overall risk of rupture and haemorrhage in all patients combined was low (1.5%). There was no significant difference between patching and primary closure but the confidence interval was wide (OR 1.24, 95% CI 0.61 to 2.54) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). None of the arterial haemorrhages was associated with a fatal or major stroke.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Local infection</HEADING>
<P>There was only a two reported case of infection at the endarterectomy site (<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>). These occured in two patients in the synthetic patching group and six patients in the primary closure group. There was no significant difference between patching and primary closure but the confidence interval was wide (OR 0.38, 95% CI 0.09 to 1.54) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Within each closure type there was significant heterogeneity<SUP> </SUP>(I<SUP>2 </SUP>= 61).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Cranial nerve palsy</HEADING>
<P>Only four trials supplied data on this outcome (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>; <LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>; <LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>; <LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>), and in one of these no outcomes occurred. The risk of nerve palsy was low (2.6%) with no significant difference between patching and primary closure (OR 0.78, 95% CI 0.36 to 1.69) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Complications requiring return to theatre</HEADING>
<P>When the number of complications (occlusion, haemorrhage, infection) that required return to theatre for re-operation within 30 days of the first operation were considered, there was a significant trend in favour of carotid patching, that is carotid patching was associated with fewer returns to theatre (OR 0.35, 95% CI 0.16 to 0.79) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes during long-term follow up (at least one year) including events during the first 30 days</HEADING>
<P>One trial followed up patients for 30 days only (<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>) and this trial has been excluded from these analyses. In the remaining trials, at least 56 patients (28 patch, 28 primary closure) were lost to follow up. These patients were assumed to be event free for the main analyses.</P>
<SUBSECTION>
<HEADING LEVEL="4">Stroke</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Any stroke (fatal, non-fatal, ipsilateral, contralateral, brainstem, infarct or haemorrhage)</HEADING>
<P>There was a significant reduction in the risk of any stroke during follow up with patching (OR 0.49, 95% CI 0.27 to 0.90, P = 0.02) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). A similar reduction was seen in fatal strokes (OR 0.27 0.05 to 1.6 P = 0.15) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) but this was based on only five events. Within each closure type there was no heterogeneity, but there was significant between-group heterogeneity (I<SUP>2 </SUP>= 72.5).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ipsilateral stroke</HEADING>
<P>Thirty-three strokes were definitely ipsilateral and one other stroke was assumed to be ipsilateral although it was unclear whether it actually was (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>). The reduction in risk of ipsilateral stroke with patching was similar to that for all strokes (OR 0.32, 95% CI 0.16 to 0.63, P = 0.001) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Death</HEADING>
<P>One-hundred-and-forty-three patients died during follow up (10.7%). Even if all patients lost to follow up were assumed to be alive, patching was associated with a non-significant reduction in the risk of death (OR 0.78, 95% CI 0.54 to 1.12, P = 0.18)(<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). Again, as outlined above, few of these deaths were directly attributable to stroke.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Any stroke or death</HEADING>
<P>Patching was associated with a significant reduction in the risk of stroke or death (OR 0.59, 95% CI 0.42 to 0.84, P = 0.004) (13% patch versus 20.6% primary closure) (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Arterial complications</HEADING>
<P>As noted in the <LINK TAG="METHODS" TYPE="SECTION">Methods</LINK> section, these results should be interpreted with caution since, in patients who underwent bilateral endarterectomies, outcomes in each artery were probably not independent. We were unable to identify how many patients with bilateral endarterectomies had outcomes events in both arteries.</P>
<SUBSECTION>
<HEADING LEVEL="5">Occlusion or restenosis greater than 50%</HEADING>
<P>Patching was associated with a highly significant reduction in the risk of arterial occlusion or restenosis (OR 0.24, 95% CI 0.17 to 0.34, P &lt; 0.00001) (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). Within each closure type there was significant heterogeneity (I<SUP>2 </SUP>= 65) and there was significant between-group heterogeneity (I<SUP>2 </SUP>= 72.4). Lack of data meant that it was not possible to correct for those patients who had died during follow up. However, the result appears to be particularly robust and is likely to remain significant even if corrected for the small numbers who died. Another problem is that the clinical significance of a reduction in occlusion or restenosis is unknown: the important outcome from the patient's point of view is a reduction in the risk of stroke. The trial by Eikelboom et al suggested that the reduction in restenosis or occlusion was confined to women, but this may be a chance subgroup effect or because women had an increased absolute risk of restenosis and so the numbers who developed restenosis were greater (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Pseudoaneurysm formation</HEADING>
<P>No pseudoaneurysms were documented during follow up of at least one year in 1141 arteries.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-07-20 12:31:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>The results of this systematic review when first published in 1995 were considered to be inconclusive, although there appeared to be promising and potentially clinically important trends in favour of routine patching in terms of both short and long-term reductions in risks of ipsilateral stroke. The results were felt to be unreliable because they were based on small number of outcome events (33 ipsilateral strokes in total), there were a number of losses to follow up and because methodological quality of the trials was on the whole poor (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). However, in the 2004 update a good quality trial including 399 operations and 45 perioperative and long term events was added (<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>) and contributed additional weight to the conclusions drawn in the previous analyses. In the current update, three new small trials have been added, which has resulted in loss of statistical significance of the apparently reduced risk of any perioperative stroke in the patching group.</P>
<P>The significant reductions in the risk of acute occlusion or long-term restenosis with patching may be less useful than data on clinically important outcomes such as stroke. Acute occlusion, though feared, is not always associated with stroke. Similarly, restenosis detected by routine Duplex scanning may not be clinically important. In some cases, remodelling of the arterial wall after endarterectomy can be mistaken for stenosis and in other cases spontaneous regression of Duplex defined stenosis has occurred (<LINK REF="REF-Bernstein-1990" TYPE="REFERENCE">Bernstein 1990</LINK>; <LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>). Moreover, in one study there was no significant association between restenosis and recurrent neurological symptoms (<LINK REF="REF-Knudsen-1990" TYPE="REFERENCE">Knudsen 1990</LINK>), whilst in another, patients with restenosis greater than 50% had a better long-term prognosis in terms of death or stroke than patients with no significant restenosis (<LINK REF="REF-Bernstein-1990" TYPE="REFERENCE">Bernstein 1990</LINK>)!</P>
<P>Most surgeons agree that carotid patching does play a role in carotid endarterectomy since they are faced with situations when this type of closure is either unavoidable or positively desirable, for example an artery with a very narrow internal diameter or a very long plaque (<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>). However, it is unclear how frequently such situations arise and how narrow an artery should be before it has to be patched. For example, only two trials in this review excluded narrow arteries on the grounds that they must be patched. One trial excluded 23% of arteries because they were less than 5 mm diameter (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>), whilst another trial excluded only 1% of arteries because they were less than 3.5 mm diameter (<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>). In the other trials, very few patients had to cross over from primary closure to patching because the artery was deemed too narrow for primary closure. A British survey also demonstrated that there is divided opinion on how often patching is required: some surgeons use it all of the time, others rarely or never (<LINK REF="REF-Girn-2008" TYPE="REFERENCE">Girn 2008</LINK>). The trials of patch versus no patch included in this review tested the policy of routinely patching all arteries against a policy of never patching in those patients in whom there was no definite indication for a patch. A policy of selective patching of only those arteries thought to require a patch at the time of operation compared to no patching has not been tested in randomised controlled trials.</P>
<P>It is possible that if patching is effective its benefit may be restricted to narrow arteries (<LINK REF="REF-Golledge-1996" TYPE="REFERENCE">Golledge 1996</LINK>). This would be analogous to carotid endarterectomy for symptomatic carotid stenosis where the benefit is restricted to those with severe artery stenosis (<LINK REF="REF-ECST-1991" TYPE="REFERENCE">ECST 1991</LINK>). We were unable to test this hypothesis because the results of the trials were not reported according to the degree of narrowing of the artery. One trial did exclude a significant number of arteries because they were less than 5 mm diameter (<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>). The results of this trial were no worse than those of the other trials, which might suggest that there is little difference in the effect of patching between arteries greater than or less than 5 mm diameter. However, such indirect comparisons between trials are unreliable.</P>
<P>There were significant methodological flaws in these trials which should be addressed in future trials. Inadequate methods of randomisation and blinding were frequently used, which can seriously bias the results of trials (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>). In most trials, the blinding of outcome assessment was unclear. Three trials mentioned blinding, but no trial assessed outcome by neurologists or stroke physicians. It is well known that studies that have neurologists as assessors are associated with higher stroke and death rates (<LINK REF="REF-Rothwell-1995" TYPE="REFERENCE">Rothwell 1995</LINK>). The trials were generally too small to achieve adequate statistical power and none were analysed on a true intention-to-treat basis, partly because there were significant losses to follow up. Problems arose with the randomisation of arteries rather than patients, and there was poor reporting of the numbers of ipsilateral strokes and disabling strokes in each treatment group.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-07-20 12:35:12 +0100" MODIFIED_BY="Hazel Fraser">
<IMPLICATIONS_PRACTICE MODIFIED="2009-07-20 12:32:50 +0100" MODIFIED_BY="Hazel Fraser">
<P>At present, most vascular surgeons in some countries such as the United Kingdom do routinely use patching in all patients undergoing carotid endarterectomy (<LINK REF="REF-Girn-2008" TYPE="REFERENCE">Girn 2008</LINK>). The results of this review provide some further support for routine patching, although more conclusive evidence is required as numbers are still small. Individual surgeons (and patients) may still interpret the evidence differently and, therefore, it is up to each surgeon to decide whether to patch routinely or not. The use of selective patching (such as for very narrow arteries) has not been studied in randomised controlled trials and so, although it is likely to be required on occasions, no clear indications for selective patching can be given.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-07-20 12:35:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>The potential benefit of routine patching could be clinically important but in order to have reliable evidence on the risks and benefits of patching compared with primary closure, a large multicentre randomised controlled trial will be required. This trial should concentrate on clinical outcomes (deaths, all strokes, particularly fatal or disabling strokes and ipsilateral strokes) as opposed to restenosis, and have long-term follow up (perhaps five years). Assuming a 30-day risk of stroke or death of 5%, the trial would need to recruit about 3000 patients to have a 90% chance of detecting a reduction in the absolute risk of death or stroke to 2.5% (this number would also give a greater-than-90% chance of detecting a reduction in the risk of stroke or death at five years from 25% to 20%). Such a trial should use a secure method of randomisation and be performed on a true intention-to-treat basis with complete follow up of all patients. Patients rather than arteries should be randomised so that the number of deaths and strokes are reported on a patient basis rather than an artery basis. Clinical follow up should be blinded with independent assessment of strokes, preferably by neurologists (<LINK REF="REF-Rerkasem-2009" TYPE="REFERENCE">Rerkasem 2009</LINK>; <LINK REF="REF-Rothwell-1995" TYPE="REFERENCE">Rothwell 1995</LINK>). The results should be analysed according to the degree of narrowing of the artery and whether the patient has had a previous stroke or transient ischaemic attack or not. It would be possible to use a factorial design for such a trial so that some other procedure could be tested simultaneously, such as routine shunting. Until the benefit of carotid patching in terms of clinical outcomes for the patient is established, any future trials should include a control group of primary closure.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-07-20 12:35:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>We would like to thank Dr Rick Bond, Professor Ali AbuRahma and Professor Ross Naylor for their contribution to previous versions of this review; and Hazel Fraser for providing us with references to relevant trials from the Cochrane Stroke Group Trials Register.</P>
<SUBSECTION>
<HEADING LEVEL="2">Ongoing trials</HEADING>
<P>If anyone is aware of any randomised trials that we have omitted, please contact Professor Peter Rothwell.</P>
</SUBSECTION>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-05-06 07:39:21 +0100" MODIFIED_BY="[Empty name]">
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-05-19 19:28:24 +0100" MODIFIED_BY="[Empty name]">
<P>Kittipan Rerkasem: designed the protocol, performed searches, selected studies for inclusion or exclusion, extracted data and updated the review.<BR/>Peter Rothwell: selected studies for inclusion or exclusion, advised on the design of the protocol, updated the review, extracted data and locally co-ordinated the update.</P>
<P>
<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-07-31 14:00:30 +0100" MODIFIED_BY="Hazel Fraser">
<STUDIES MODIFIED="2009-07-31 13:59:59 +0100" MODIFIED_BY="Hazel Fraser">
<INCLUDED_STUDIES MODIFIED="2009-07-31 13:59:59 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-AbuRahma-1996" MODIFIED="2008-09-09 20:40:16 +0100" MODIFIED_BY="[Empty name]" NAME="AbuRahma 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-09-09 20:40:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>AbuRahma AF, Khan JH, Robinson PA, Saiedy S, Short YS, Boland JP, et al</AU>
<TI>Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: perioperative (30 day) results</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1996</YR>
<VL>24</VL>
<PG>998-1007</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>AbuRahma AF, Robinson PA, Saiedy S, Kahn JH, Boland JP</AU>
<TI>Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>222-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Rawi-2006" MODIFIED="2009-07-20 13:32:36 +0100" MODIFIED_BY="Hazel Fraser" NAME="Al-Rawi 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-20 13:32:36 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Rawi PG, Turner CL, Waran V, Ng I, Kirkpatrick PJ</AU>
<TI>A randomized trial of synthetic patch versus direct primary closure in carotid endarterectomy</TI>
<SO>Neurosurgery</SO>
<YR>2006</YR>
<VL>59</VL>
<PG>822-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Eikelboom-1988" MODIFIED="2008-09-09 20:40:27 +0100" MODIFIED_BY="[Empty name]" NAME="Eikelboom 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-09-09 20:40:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-09-09 20:40:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Eikelboom BC, Ackerstaff RGA, Hoeneveld H, Ludwig JW, Teeuwen C, Vermeulen FEE, et al</AU>
<TI>Benefits of carotid patching: a randomized study</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1988</YR>
<VL>7</VL>
<PG>240-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Letter JAM, Moll FL, Welten RJT, Eikelboom BC, Ackerstaff RGA, Vermeulen FEE, et al</AU>
<TI>Benefits of carotid patching: a prospective randomized study with long-term follow-up</TI>
<SO>Annals of Vascular Surgery</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>54-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Katz-1994" NAME="Katz 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz D, Snyder SO, Gandhi RH, Wheeler JR, Gregory RT, Gayle RG, et al</AU>
<TI>Long-term follow up for recurrent stenosis: a prospective randomized study of expanded polytetrafluoroethylene patch angioplasty versus primary closure after carotid endarterectomy</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1994</YR>
<VL>19</VL>
<PG>198-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lord-1989" NAME="Lord 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lord RSA, Raj TB, Stary DL, Nash PA, Graham AR, Goh KH</AU>
<TI>Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy. Part I: Perioperative results</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1989</YR>
<VL>9</VL>
<PG>521-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mannheim-2005" MODIFIED="2009-07-20 13:33:15 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mannheim 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-07-20 13:33:15 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mannheim D, Weller B, Vahadim E, Karmeli R</AU>
<TI>Carotid endarterectomy with a polyurethane patch versus primary closure: a prospective randomized study</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2005</YR>
<VL>41</VL>
<PG>403-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Myers-1994" MODIFIED="2009-07-20 13:46:09 +0100" MODIFIED_BY="Hazel Fraser" NAME="Myers 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clagett GP, Patterson CB, Fisher Jr DF, Fry RE, Eidt JF, Humble TH, et al</AU>
<TI>Vein patch versus primary closure for carotid endarterectomy. A randomized prospective study in a selected group of patients</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1989</YR>
<VL>9</VL>
<PG>213-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-07-20 13:46:09 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Myers SI, Valentine RJ, Chervu A, Bowers BL, Clagett GP</AU>
<TI>Saphenous vein patch versus primary closure for carotid endarterectomy: long term assessment of a randomized prospective study</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1994</YR>
<VL>19</VL>
<PG>15-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pratesi-1986" MODIFIED="2009-07-20 13:34:46 +0100" MODIFIED_BY="Hazel Fraser" NAME="Pratesi 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-07-20 13:34:46 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Pratesi C, Frullini A, Rega L, Fonda C, Matticari S, Alessi Innocenta A, et al</AU>
<TI>The follow-up after carotid TEA</TI>
<SO>Trends and Controversies</SO>
<YR>1986</YR>
<VL>1</VL>
<PG>313-5</PG>
<ED>Maurer PC, Becker HM, Heidrich H, Hoffmann G, Kriessmann A, Muller-Wiefel H, Pratorius C.</ED>
<PB>W Zuckschwerdt</PB>
<CY>Munich</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ranaboldo-1993" MODIFIED="2009-07-31 13:59:59 +0100" MODIFIED_BY="Hazel Fraser" NAME="Ranaboldo 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-07-31 13:59:59 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-07-31 13:59:59 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ranaboldo CJ, Barros D'Sa ABB, Bell PRF, Chant ADB, Perry PM; the Joint Vascular Research Group</AU>
<TI>Randomized controlled trial of patch angioplasty for carotid endarterectomy</TI>
<SO>British Journal of Surgery</SO>
<YR>1993</YR>
<VL>80</VL>
<PG>1528-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Vleeschauwer-1987" MODIFIED="2009-07-20 13:34:53 +0100" MODIFIED_BY="Hazel Fraser" NAME="Vleeschauwer 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-07-20 13:34:53 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Vleeschauwer P, Wirthle W, Holler L, Krause E, Horsch S</AU>
<TI>Is venous patch grafting after carotid endarterectomy able to reduce the rate of restenosis? Prospective randomized pilot study with stratification</TI>
<SO>Acta Chirurgica Belgica</SO>
<YR>1987</YR>
<VL>87</VL>
<PG>242-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Gale-1985" NAME="Gale 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gale S</AU>
<TI>Carotid endarterectomy with and without vein patch: a prospective randomized study</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1988</YR>
<VL>7</VL>
<PG>240-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hertzer-1987" NAME="Hertzer 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hertzer NR, Beven EG, O'Hara PJ, Krajewski LP</AU>
<TI>A prospective study of vein patch angioplasty during carotid endarterectomy. Three-year results for 801 patients and 917 operations</TI>
<SO>Annals of Surgery</SO>
<YR>1987</YR>
<VL>206</VL>
<PG>628-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-07-31 14:00:30 +0100" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_REFERENCES MODIFIED="2009-07-31 14:00:30 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-ACAS-1995" NAME="ACAS 1995" TYPE="JOURNAL_ARTICLE">
<AU>Executive Committee for the Asymptomatic Carotid Atherosclerosis Study</AU>
<TI>Endarterectomy for asymptomatic carotid artery stenosis</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>18</NO>
<PG>1421-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APT-1994" MODIFIED="2009-07-31 14:00:30 +0100" MODIFIED_BY="Hazel Fraser" NAME="APT 1994" TYPE="JOURNAL_ARTICLE">
<AU>Antiplatelet Trialists' Collaboration</AU>
<TI>Collaborative overview of trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>308</VL>
<PG>81-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Awad-1989" NAME="Awad 1989" TYPE="JOURNAL_ARTICLE">
<AU>Awad IA, Little JR</AU>
<TI>Patch angioplasty in carotid endarterectomy. Advantages, concerns, and controversies</TI>
<SO>Stroke</SO>
<YR>1989</YR>
<VL>20</VL>
<PG>417-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bernstein-1990" NAME="Bernstein 1990" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein EF, Torem S, Dilley RB</AU>
<TI>Does carotid restenosis predict an increased risk of late symptoms, stroke or death?</TI>
<SO>Annals of Surgery</SO>
<YR>1990</YR>
<VL>212</VL>
<PG>629-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bernstein-1992" NAME="Bernstein 1992" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein EF</AU>
<TI>Routine versus selective carotid patching</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1992</YR>
<VL>15</VL>
<PG>868-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bond-2003" MODIFIED="2008-09-09 20:41:43 +0100" MODIFIED_BY="[Empty name]" NAME="Bond 2003" TYPE="COCHRANE_REVIEW">
<AU>Bond R, Rerkasem K, Naylor AR, Rothwell PM</AU>
<TI>Patches of different types for carotid patch angioplasty</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<PB>John Wiley &amp; Sons Ltd</PB>
<CY>Chichester</CY>
<IDENTIFIERS MODIFIED="2008-09-09 20:41:35 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-09-09 20:41:35 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="Art. No.: CD000071. DOI: 10.1002/14651858.CD000071"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Das-1985" NAME="Das 1985" TYPE="JOURNAL_ARTICLE">
<AU>Das MB, Hertzer NR, Ratliff NB, O'Hara PJ, Beven EG</AU>
<TI>Recurrent carotid stenosis. A five-year series of 65 reports</TI>
<SO>Annals of Surgery</SO>
<YR>1985</YR>
<VL>202</VL>
<PG>28-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ECST-1991" NAME="ECST 1991" TYPE="JOURNAL_ARTICLE">
<AU>European Carotid Surgery Trialists' Collaborative Group</AU>
<TI>MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>337</VL>
<PG>1235-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Frericks-1998" NAME="Frericks 1998" TYPE="JOURNAL_ARTICLE">
<AU>Frericks H, Kievit J, van Baalen JM, van Bockel JH</AU>
<TI>Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature</TI>
<SO>Stroke</SO>
<YR>1998</YR>
<VL>29</VL>
<PG>244-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Girn-2008" MODIFIED="2009-07-20 13:36:33 +0100" MODIFIED_BY="Hazel Fraser" NAME="Girn 2008" TYPE="JOURNAL_ARTICLE">
<AU>Girn HRS, Dellagrammaticas D, Laughlan K, Gough MJ, on behalf of the GALA Trial Collaborators</AU>
<TI>Carotid endarterectomy: technical practices of surgeons participating in the GALA trial</TI>
<SO>European Journal of Vascular and Endovascular Surgery</SO>
<YR>2008</YR>
<VL>36</VL>
<PG>385-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Golledge-1996" MODIFIED="2009-07-20 13:36:56 +0100" MODIFIED_BY="Hazel Fraser" NAME="Golledge 1996" TYPE="JOURNAL_ARTICLE">
<AU>Golledge J, Cuming R, Davies AH, Greenhalgh RM</AU>
<TI>Outcome of selective patching following carotid endarterectomy</TI>
<SO>European Journal of Vascular and Endovascular Surgery</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>458-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halliday-2004" MODIFIED="2009-07-20 13:37:47 +0100" MODIFIED_BY="Hazel Fraser" NAME="Halliday 2004" TYPE="JOURNAL_ARTICLE">
<AU>Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al</AU>
<TI>Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2004</YR>
<VL>363</VL>
<PG>1491-502</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2009-07-20 13:37:52 +0100" MODIFIED_BY="Hazel Fraser" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Knudsen-1990" NAME="Knudsen 1990" TYPE="JOURNAL_ARTICLE">
<AU>Knudsen L, Sillesen H, Schroeder T, Hansen HJB</AU>
<TI>Eight to ten years follow-up after carotid endarterectomy: clinical evaluation and doppler examination of patients operated on between 1978-1980</TI>
<SO>European Journal of Vascular Surgery</SO>
<YR>1990</YR>
<VL>4</VL>
<PG>259-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ouriel-1987" NAME="Ouriel 1987" TYPE="JOURNAL_ARTICLE">
<AU>Ouriel K, Green RM</AU>
<TI>Clinical and technical factors influencing recurrent carotid stenosis and occlusion after endarterectomy</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>1987</YR>
<VL>5</VL>
<PG>702-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rerkasem-2009" MODIFIED="2009-07-20 13:38:31 +0100" MODIFIED_BY="Hazel Fraser" NAME="Rerkasem 2009" TYPE="JOURNAL_ARTICLE">
<AU>Rerkasem K, Rothwell PM</AU>
<TI>Temporal trends in the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis: an updated systematic review</TI>
<SO>European Journal of Vascular and Endovascular Surgery</SO>
<YR>2009</YR>
<VL>37</VL>
<PG>504-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rothwell-1995" NAME="Rothwell 1995" TYPE="JOURNAL_ARTICLE">
<AU>Rothwell P, Warlow C</AU>
<TI>Is self-audit reliable?</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>346</VL>
<PG>1623</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rothwell-2003" MODIFIED="2009-07-20 13:38:53 +0100" MODIFIED_BY="Hazel Fraser" NAME="Rothwell 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al</AU>
<TI>Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>361</VL>
<PG>107-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Volteas-1994" NAME="Volteas 1994" TYPE="JOURNAL_ARTICLE">
<AU>Volteas N, Labropoulos N, Leon M, Kalodiki E, Chan P, Nicolaides AN</AU>
<TI>Risk factors associated with recurrent carotid stenosis</TI>
<SO>International Angiology</SO>
<YR>1994</YR>
<VL>13</VL>
<PG>143-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zierler-1982" NAME="Zierler 1982" TYPE="JOURNAL_ARTICLE">
<AU>Zierler RE, Bandyk DF, Thiele BL, Strandness Jr DE</AU>
<TI>Carotid artery stenosis following endarterectomy</TI>
<SO>Archives of Surgery</SO>
<YR>1982</YR>
<VL>117</VL>
<PG>1408-15</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-07-20 13:46:32 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Bond-2004" MODIFIED="2009-07-20 13:41:35 +0100" MODIFIED_BY="Hazel Fraser" NAME="Bond 2004" TYPE="COCHRANE_REVIEW">
<AU>Bond R, Rerkasem K, AbuRahma AF, Naylor AR, Rothwell PM</AU>
<TI>Patch angioplasty versus primary closure for carotid endarterectomy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2009-07-20 13:41:35 +0100" MODIFIED_BY="Hazel Fraser">
<IDENTIFIER MODIFIED="2009-07-20 13:41:35 +0100" MODIFIED_BY="Hazel Fraser" TYPE="DOI" VALUE="Art. No.: CD000160. DOI: 10.1002/14651858.CD000160.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Counsell-1996" MODIFIED="2009-07-20 13:46:32 +0100" MODIFIED_BY="Hazel Fraser" NAME="Counsell 1996" TYPE="COCHRANE_REVIEW">
<AU>Counsell C, Salinas R, Warlow C, Naylor R</AU>
<TI>Patch angioplasty versus primary closure for carotid endarterectomy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1996</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-09-09 20:42:33 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-09-09 20:42:33 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="Art. No.: CD000160. DOI: 10.1002/14651858.CD000160"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-07-31 13:58:47 +0100" MODIFIED_BY="Hazel Fraser">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-07-31 13:58:47 +0100" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-07-20 12:58:09 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-AbuRahma-1996">
<CHAR_METHODS MODIFIED="2009-07-20 12:56:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = computer-generated sealed envelopes (artery randomised)<BR/>Both duplex and clinical FU blinded<BR/>Crossovers: 4 patients in vein group underwent primary closure and were excluded from the trial; 3 jugular vein patients had saphenous vein and were included in trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 12:56:46 +0100" MODIFIED_BY="Hazel Fraser">
<P>USA<BR/>357 patients, 399 operations in three arms: 130 vein, 134 PTFE and 135 primary closure<BR/>50% male<BR/>Mean age: 68 years<BR/>33% asymptomatic<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease similar in each group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 12:57:31 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: polytetrafluoroethylene patch or alternating saphenous vein patch (from ankle) and jugular vein<BR/>Control: primary closure<BR/>Routine shunting for all and GA<BR/>325 mg daily aspirin was started within 24 hours of surgery for all patients</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-20 12:57:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>Death, ipsilateral stroke, ipsilateral TIA and ipsilateral RIND at 30 days and 48 months<BR/>Duplex evidence of restenosis &gt; 50% during follow up</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 12:58:09 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: patients with ICA &lt; 4 mm or combined CABG or redo surgery<BR/>FU: mean 30 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:01:48 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Al_x002d_Rawi-2006">
<CHAR_METHODS MODIFIED="2009-07-20 12:58:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = envelope<BR/>Duplex blind, clinical FU not blind<BR/>Crossovers: unknown<BR/>Indication for shunt in any sign of ischaemia from transcranial Doppler, cerebral function monitor, near infrared spectrscopy, Doppler flowmetry<BR/>Exclusion during trial: none<BR/>Patients lost to FU: 7 patch, 8 no patch</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 12:58:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>England<BR/>321 patients<BR/>338 operations<BR/>68% male<BR/>Mean age: 69 years<BR/>10% asymptomatic carotid disease<BR/>% stenosis unknown<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease were similar in each group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 12:59:25 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: collagen-coated polyester vascular patch<BR/>Control: primary closure<BR/>% shunted: unknown<BR/>After surgery, all patients were given rectal aspirin (600 mg)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-20 12:59:44 +0100" MODIFIED_BY="Hazel Fraser">
<P>Deaths &lt; 30 days and end of FU<BR/>Strokes &lt; 30 days and end of FU<BR/>Perioperative occlusion<BR/>Bleeding or evacuation clot<BR/>Cardiac event<BR/>Restenosis &gt; 50% or occlusion at end of FU (ultrasound)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 13:01:48 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: 10 patients due to: poor cerebral blood flow (3 patients), ST depression (1 patient), high tortuosity (6 patients)<BR/>FU: 12 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:09:51 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Eikelboom-1988">
<CHAR_METHODS MODIFIED="2009-07-20 13:08:44 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = odd/even hospital number (patients randomised)<BR/>Duplex blind, clinical FU not blind<BR/>Crossovers: 3 primary closure to patch, 3 patch to primary closure (all analysed in original group)<BR/>Exclusion during trial: none<BR/>Patients lost to FU: 10 patch, 7 no patch<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:09:02 +0100" MODIFIED_BY="Hazel Fraser">
<P>The Netherlands<BR/>126 patients<BR/>129 operations<BR/>73% male<BR/>Mean age: 63 years<BR/>18% asymptomatic carotid disease<BR/>All arteries &gt; 60% stenosis<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease were similar in each group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:09:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: saphenous vein patch<BR/>Control: primary closure<BR/>20% shunted<BR/>Postoperative warfarin +/- antiplatelet for all<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Deaths &lt; 30 days and end of FU<BR/>Strokes &lt; 30 days and end of FU<BR/>Perioperative occlusion (intravenous DSA)<BR/>Wound haemorrhage<BR/>Restenosis &gt; 50% or occlusion at end of FU (Duplex and intravenous DSA)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 13:09:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: simultaneous cardiac surgery<BR/>FU: mean 5 years</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-31 13:58:47 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Katz-1994">
<CHAR_METHODS MODIFIED="2009-07-20 13:09:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = odd/even social security number (patients randomised)<BR/>Neither duplex nor clinical FU blind<BR/>Crossovers: none<BR/>Exclusions during trial: none<BR/>Patients lost to FU: 12 in total<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:10:09 +0100" MODIFIED_BY="Hazel Fraser">
<P>USA<BR/>87 patients<BR/>100 operations<BR/>56% male<BR/>Mean age: 67 years<BR/>40% asymptomatic carotid disease<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease were similar in each group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:10:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: polytetrafluoroethylene patch<BR/>Control: primary closure<BR/>Routine shunting for all<BR/>Postoperative aspirin (325 mg) for all<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Death &lt; 30 days and end of FU<BR/>Stroke &lt; 30 days and end of FU<BR/>Perioperative occlusion (Duplex)<BR/>Wound haemorrhage, infection, cranial nerve palsy<BR/>Restenosis &gt; 50% or occlusion at end of FU (Duplex)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-31 13:58:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: previous endarterectomy, simultaneous cardiac surgery, internal carotid artery diameter &lt; 3.5 mm<BR/>FU: mean 29 months<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-31 13:58:35 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Lord-1989">
<CHAR_METHODS MODIFIED="2009-07-20 13:10:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = sealed envelopes (artery randomised)<BR/>Probably neither duplex nor clinical FU blind<BR/>Crossovers: 4 (unclear which group these were in)<BR/>Exclusions during trial: 4 crossovers<BR/>Patients lost to FU: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:11:05 +0100" MODIFIED_BY="Hazel Fraser">
<P>Australia<BR/>123 patients<BR/>140 operations.<BR/>62% male<BR/>Mean age: 63 years<BR/>% asymptomatic carotid disease unknown<BR/>Comparability: age, sex, vascular risk factors, % symptomatic disease similar in each group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:11:14 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: saphenous vein patch or polytetrafluoroethylene patch (random allocation)<BR/>Control: primary closure<BR/>17% shunted<BR/>Postoperative aspirin for all</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Ipsilateral stroke &lt; 30 days<BR/>Perioperative occlusion (intravenous DSA)<BR/>Wound haemorrhage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-31 13:58:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: unknown<BR/>FU: until hospital discharge<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:12:07 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Mannheim-2005">
<CHAR_METHODS MODIFIED="2009-07-20 13:11:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = sealed envelopes<BR/>Duplex and clinical FU unknown for blinding<BR/>Crossovers: none<BR/>Exclusions during trial: none<BR/>Patients lost to FU: unknown<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:11:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>Israel<BR/>404 patients<BR/>422 operations<BR/>65.6% male<BR/>Mean age: 69.5 years<BR/>53.7% asymptomatic carotid disease<BR/>Comparability: sex, vascular risk factors, % asymptomatic disease similar in each group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:12:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: polyester urethane patch angioplasty<BR/>Control: primary closure<BR/>Indication shunt for change in neurological status during carotid clamping or in patients in general anesthesia with stump pressure &lt; 40 mmHg<BR/>Peri and postoperative aspirin: unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-05-19 19:29:47 +0100" MODIFIED_BY="[Empty name]">
<P>Death &lt; 30 days and end of FU<BR/>Stroke &lt; 30 days and end of FU<BR/>Coronary event<BR/>Wound haemorrhage, infection, cranial nerve palsy<BR/>Restenosis &gt; 50% or occlusion at end of FU (Duplex)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-05-19 19:30:00 +0100" MODIFIED_BY="[Empty name]">
<P>Ex: small ICA or need for interposition graft<BR/>FU: 5 years</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:14:10 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Myers-1994">
<CHAR_METHODS MODIFIED="2009-07-20 13:13:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = opaque, sequentially numbered sealed envelopes (artery randomised)<BR/>Duplex blind, clinical FU not blind<BR/>Crossovers: none<BR/>Exclusions during trial: none<BR/>Patients lost to FU: 6 patch, 8 no patch<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:13:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>USA<BR/>136 (109) patients<BR/>152 (126) operations<BR/>99% male<BR/>Mean age: 62 years<BR/>23% asymptomatic carotid disease<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease similar in each group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:13:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: saphenous vein patch<BR/>Control: primary closure<BR/>Routine shunt for all<BR/>Peri and postoperative aspirin (325 mg) for all</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Death &lt; 30 days and end of FU<BR/>Stroke &lt; 30 days and end of FU<BR/>Perioperative occlusion (ocular pneumoplethysmography)<BR/>Wound haemorrhage, infection, cranial nerve palsy<BR/>Restenosis &gt; 50% or occlusion at end of FU (Duplex)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 13:14:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: ICA diameter &lt; 5mm, arteriotomy &gt; 3 cm, looped or kinked ICA<BR/>FU: 4 to 5 years<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:18:37 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Pratesi-1986">
<CHAR_METHODS MODIFIED="2009-07-20 13:14:26 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = unknown<BR/>Duplex and clinical FU: unknown<BR/>Crossovers: unknown<BR/>Exclusions during trial: unknown<BR/>Patients lost to FU: unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:14:48 +0100" MODIFIED_BY="Hazel Fraser">
<P>Italy<BR/>90 patients<BR/>100 operations<BR/>Ratio: male:female 6:5<BR/>Mean age: unknown<BR/>10% asymptomatic carotid disease<BR/>% stenosis: unknown<BR/>Comparability: age, sex, vascular risk factors not reported by treatment group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:18:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: % autologous vein or synthetic (unknown)<BR/>Control: primary closure<BR/>Shunt: unknown indication<BR/>Aspirin before surgery, unknown after surgery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-07-20 13:15:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>Death &lt; 30 days and FU period<BR/>Stroke &lt; 30 days and FU period<BR/>Restenosis FU period (by DSA)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 13:15:44 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: unknown<BR/>FU: 2 years</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:16:42 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ranaboldo-1993">
<CHAR_METHODS MODIFIED="2009-07-20 13:16:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>R = opaque, sequentially-numbered, sealed envelopes (artery randomised)<BR/>Duplex and clinical FU blind<BR/>Crossovers: 4 primary closure to patch (all analysed in original group)<BR/>Exclusions during trial: none<BR/>Patients lost to FU: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:16:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>United Kingdom<BR/>199 patients<BR/>213 operations<BR/>69% male<BR/>Mean age: 66 years<BR/>8% asymptomatic carotid disease<BR/>60% arteries &gt; 75% stenosis<BR/>Comparability: age, sex, vascular risk factors not reported by treatment group<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:16:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: autologous vein (N = 53) or Dacron (N = 56) patches (non-random allocation)<BR/>Control: primary closure<BR/>Shunt 'when technically possible'<BR/>Aspirin before surgery, unknown after surgery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Death &lt; 30 days and end of FU<BR/>Stroke &lt; 30 days and end of FU<BR/>Perioperative occlusion (Duplex)<BR/>Wound haemorrhage, infection<BR/>Restenosis &gt; 50% or occlusion at end of FU (Duplex)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Ex: unknown<BR/>FU: 12 months<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-07-20 13:19:37 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Vleeschauwer-1987">
<CHAR_METHODS MODIFIED="2009-07-20 13:19:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>R - sealed envelopes (not opaque or numbered)<BR/>Clinical and Duplex FU blind<BR/>Crossovers: none<BR/>Exclusions during trial: patients with residual stenosis/occlusion (number known)<BR/>Patients lost to FU: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-07-20 13:19:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>Germany<BR/>126 patients<BR/>174 operations<BR/>60% male<BR/>Mean age: 64 years<BR/>30% asymptomatic carotid disease<BR/>Comparability: age, sex, vascular risk factors, % asymptomatic disease not reported by treatment group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-07-20 13:19:26 +0100" MODIFIED_BY="Hazel Fraser">
<P>Rx: autologous vein patch<BR/>Control: primary closure<BR/>Routine shunting for all<BR/>Postoperative aspirin (1 g) for all</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Death &lt; 30 days and end of FU<BR/>Stroke &lt; 30 days and end of FU<BR/>Wound haemorrhage, infection<BR/>Restensosis &gt; 50% or occlusion at end of FU (Duplex)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-20 13:19:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>Ex: Recurrent stenosis, kinked ICA<BR/>FU: 1 year</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CABG: coronary artery bypass graft<BR/>DSA: digital subtraction angiography<BR/>Ex: exclusion criteria<BR/>FU: follow up<BR/>GA: general anaesthesia<BR/>ICA: internal carotid artery<BR/>R: concealment of allocation<BR/>RIND: reversible ischaemic neurological deficit<BR/>Rx: treatment<BR/>TIA: transient ischaemic attack<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-07-20 13:21:00 +0100" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-07-20 13:21:00 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Gale-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-20 13:21:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>Randomised by flipping a coin<BR/>Not intention-to-treat<BR/>About 300 patients randomised to either vein patch or primary closure: 194 patients had the operation to which they were randomised, the remaining patients were randomised to 1 procedure but actually had the other procedure for some reason<BR/>Results only available for the 194 patients who remained in the group to which they were originally allocated</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hertzer-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-random comparison of patching performed by one surgeon and primary closure performed by other surgeons in the same institute (personal communication with Dr Hertzer)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-07-20 13:15:53 +0100" MODIFIED_BY="Hazel Fraser">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-07-20 13:15:53 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-AbuRahma-1996">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-20 13:13:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Al_x002d_Rawi-2006">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Eikelboom-1988">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Katz-1994">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-1989">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-20 13:13:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Mannheim-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Myers-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-20 13:15:53 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Pratesi-1986">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ranaboldo-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 09:55:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vleeschauwer-1987">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-05-06 09:55:43 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2009-07-20 13:47:43 +0100" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2009-07-20 13:47:43 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE>Number of cases lost to follow up</TITLE>
<TABLE COLS="10" ROWS="11">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Total patients</P>
</TH>
<TH>
<P>Total operations</P>
</TH>
<TH>
<P>Patch lost at 30 days</P>
</TH>
<TH>
<P>Patch lost at end</P>
</TH>
<TH>
<P>Primary lost at 30 days</P>
</TH>
<TH>
<P>Primary lost at end</P>
</TH>
<TH>
<P>Number of exclusions</P>
</TH>
<TH>
<P>Crossover patch - non</P>
</TH>
<TH>
<P>Crossover non - patch</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-AbuRahma-1996" TYPE="STUDY">AbuRahma 1996</LINK>
</P>
</TD>
<TD>
<P>357</P>
</TD>
<TD>
<P>399</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Al_x002d_Rawi-2006" TYPE="STUDY">Al-Rawi 2006</LINK>l</P>
</TD>
<TD>
<P>315</P>
</TD>
<TD>
<P>338</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Eikelboom-1988" TYPE="STUDY">Eikelboom 1988</LINK>
</P>
</TD>
<TD>
<P>126</P>
</TD>
<TD>
<P>129</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>10 patients lost to doppler FU but not clinical FU</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>7 to doppler FU but not clinical FU</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Katz-1994" TYPE="STUDY">Katz 1994</LINK>
</P>
</TD>
<TD>
<P>87</P>
</TD>
<TD>
<P>100</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lord-1989" TYPE="STUDY">Lord 1989</LINK>
</P>
</TD>
<TD>
<P>123</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>Between 0 and 4</P>
</TD>
<TD>
<P>Between 0 and 4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Mannheim-2005" TYPE="STUDY">Mannheim 2005</LINK>
</P>
</TD>
<TD>
<P>404</P>
</TD>
<TD>
<P>422</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Myers-1994" TYPE="STUDY">Myers 1994</LINK>
</P>
</TD>
<TD>
<P>136 (109 after exclusion of 27 patients undergoing obligatory vein patching)</P>
</TD>
<TD>
<P>152 (122 analysed as 30 operations got obligatory vein patches)</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>30 operations underwent obligatory vein patch closure and 16 patients had both sides done (total 46)</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pratesi-1986" TYPE="STUDY">Pratesi 1986</LINK>
</P>
</TD>
<TD>
<P>100</P>
</TD>
<TD>
<P>100</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ranaboldo-1993" TYPE="STUDY">Ranaboldo 1993</LINK>
</P>
</TD>
<TD>
<P>199</P>
</TD>
<TD>
<P>213</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0 at 30-day FU but 4 at 1-year FU</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Vleeschauwer-1987" TYPE="STUDY">Vleeschauwer 1987</LINK>
</P>
</TD>
<TD>
<P>126</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>Data not available</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>FU: follow up</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-07-20 13:42:43 +0100" MODIFIED_BY="Hazel Fraser">
<COMPARISON ID="CMP-001" MODIFIED="2009-07-20 13:42:26 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Patch versus no patch: perioperative complications &lt; 30 days</NAME>
<DICH_OUTCOME CHI2="6.68538311777093" CI_END="1.0322706073121368" CI_START="0.31005113969694115" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5657355197199321" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="27" I2="10.251964707139376" I2_Q="60.33831014277218" ID="CMP-001.01" LOG_CI_END="0.013793561493570479" LOG_CI_START="-0.5085666679190854" LOG_EFFECT_SIZE="-0.24738655321275743" METHOD="PETO" MODIFIED="2009-05-05 10:48:59 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3509250311556069" P_Q="0.08035316600158326" P_Z="0.06338894701434625" Q="5.042649486694844" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="936" TOTAL_2="833" WEIGHT="100.0" Z="1.8564534865209585">
<NAME>Any stroke: fatal and non-fatal</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.287853292125823" CI_END="1.7184612480216936" CI_START="0.08400168346900269" DF="1.0" EFFECT_SIZE="0.379938992221206" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.23513974307196459" LOG_CI_START="-1.075712010200355" LOG_EFFECT_SIZE="-0.4202861335641953" NO="1" P_CHI2="0.5915995586559043" P_Z="0.20882253007720686" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="15.879361998019489" Z="1.2568098306022353">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="2.3156808503757604" CI_START="0.087982896702992" EFFECT_SIZE="0.45137601736878674" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.364678704247277" LOG_CI_START="-1.0556017436388139" LOG_EFFECT_SIZE="-0.34546151969576844" ORDER="78458" O_E="-1.1428571428571428" SE="0.8342797655898933" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="1.4367346938775512" WEIGHT="13.526704137207407"/>
<DICH_DATA CI_END="7.116970904304022" CI_START="0.0027971650222280136" EFFECT_SIZE="0.14109338070134148" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8522951903420245" LOG_CI_START="-2.5532819111297607" LOG_EFFECT_SIZE="-0.8504933603938682" ORDER="78459" O_E="-0.48936170212765956" SE="2.0004528472830594" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.24988682661837933" WEIGHT="2.3526578608120823"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78460" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2769921278763035" CI_END="3.0725425758118208" CI_START="0.4950853638225289" DF="2.0" EFFECT_SIZE="1.2333575552150338" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.48749790956077843" LOG_CI_START="-0.3053199124991926" LOG_EFFECT_SIZE="0.09108899853079287" MODIFIED="2009-05-05 10:48:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5280860621606865" P_Z="0.652442809899046" STUDIES="3" TAU2="0.0" TOTAL_1="402" TOTAL_2="435" WEIGHT="43.410361191650736" Z="0.45037119888223553">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="3.6442624006446778" CI_START="0.3626680439813911" EFFECT_SIZE="1.1496336445132134" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5616096402683559" LOG_CI_START="-0.4404907100218888" LOG_EFFECT_SIZE="0.06055946512323352" MODIFIED="2009-05-05 10:48:59 +0100" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.4024390243902438" SE="0.5886387062372253" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="153" TOTAL_2="175" VAR="2.8860401464833627" WEIGHT="27.171760629113283"/>
<DICH_DATA CI_END="5.10906223973841" CI_START="0.052381715424602196" EFFECT_SIZE="0.5173214129809031" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7083411933869612" LOG_CI_START="-1.2808202831685205" LOG_EFFECT_SIZE="-0.2862395448907797" ORDER="78461" O_E="-0.48275862068965525" SE="1.1684432978368013" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.732461355529132" WEIGHT="6.896045658534692"/>
<DICH_DATA CI_END="20.553690501357416" CI_START="0.40170631076971874" EFFECT_SIZE="2.8734208156834424" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3128898126098902" LOG_CI_START="-0.3960913454878034" LOG_EFFECT_SIZE="0.45839923356104345" MODIFIED="2009-05-05 10:28:29 +0100" MODIFIED_BY="[Empty name]" ORDER="97" O_E="1.04739336492891" SE="1.0038639918597525" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="0.9923165779249281" WEIGHT="9.34255490400276"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07788821107395871" CI_END="0.738708702508877" CI_START="0.11214653824213297" DF="1.0" EFFECT_SIZE="0.28782568293275745" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="-0.13152678465395362" LOG_CI_START="-0.9502141277479152" LOG_EFFECT_SIZE="-0.5408704562009343" NO="3" P_CHI2="0.7801799135668782" P_Z="0.009605326027580088" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="40.71027681032977" Z="2.5897227394510067">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.9043331039534062" CI_START="0.07204208951961158" EFFECT_SIZE="0.2552450713149218" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="-0.04367157111484767" LOG_CI_START="-1.1424136993272842" LOG_EFFECT_SIZE="-0.5930426352210658" ORDER="78462" O_E="-3.2781954887218046" SE="0.6454065649732366" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="2.400674296918478" WEIGHT="22.602092844694855"/>
<DICH_DATA CI_END="1.3740896182727078" CI_START="0.08137360033625522" EFFECT_SIZE="0.3343869307008287" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.1380150583800675" LOG_CI_START="-1.0895164684264385" LOG_EFFECT_SIZE="-0.4757507050231855" ORDER="78463" O_E="-2.1069518716577544" SE="0.7210580952251979" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="1.9233551560414344" WEIGHT="18.108183965634918"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6369287670715695" CI_END="4.562656386504064" CI_START="0.048580804458867366" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4708051802240034" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.6592177633016366" LOG_CI_START="-1.3135352979056445" LOG_EFFECT_SIZE="-0.32715876730200394" METHOD="PETO" MODIFIED="2009-05-05 10:29:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4248253670126123" P_Q="0.4248253670126123" P_Z="0.5156433369446098" Q="0.6369287670715695" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="783" TOTAL_2="658" WEIGHT="100.0" Z="0.6500756873706597">
<NAME>Stroke-related death</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.730175884304742" CI_START="0.056003177358866146" DF="0.0" EFFECT_SIZE="0.908260233950607" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="1.1682079325267425" LOG_CI_START="-1.2517873324531381" LOG_EFFECT_SIZE="-0.04178969996319784" NO="1" P_CHI2="1.0" P_Z="0.9460313788942672" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="66.45327965843218" Z="0.06769129513423536">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="14.730175884304742" CI_START="0.056003177358866146" EFFECT_SIZE="0.908260233950607" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1682079325267425" LOG_CI_START="-1.2517873324531381" LOG_EFFECT_SIZE="-0.04178969996319784" ORDER="78464" O_E="-0.04761904761904767" SE="1.4215171978189411" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="0.49487528344671206" WEIGHT="66.45327965843218"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78465" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78466" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-05-05 10:29:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="249" TOTAL_2="260" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78467" O_E="0.0" SE="0.0" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-05 10:29:26 +0100" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.0" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.464882784320752" CI_START="0.0025382637589824366" DF="0.0" EFFECT_SIZE="0.12809987383877797" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="0.8105606550347918" LOG_CI_START="-2.5954632509888156" LOG_EFFECT_SIZE="-0.8924512979770118" NO="3" P_CHI2="1.0" P_Z="0.3043709532440402" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="33.54672034156783" Z="1.027105182026191">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78468" O_E="0.0" SE="0.0" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.464882784320752" CI_START="0.0025382637589824366" EFFECT_SIZE="0.12809987383877797" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8105606550347918" LOG_CI_START="-2.5954632509888156" LOG_EFFECT_SIZE="-0.8924512979770118" ORDER="78469" O_E="-0.5133689839572193" SE="2.000715302488518" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="0.24982127026795167" WEIGHT="33.54672034156783"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9925226560119509" CI_END="0.6251746469565134" CI_START="0.151610541755387" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.3078685870900274" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.2039986424732983" LOG_CI_START="-0.8192706003726706" LOG_EFFECT_SIZE="-0.5116346214229844" METHOD="PETO" NO="3" P_CHI2="0.9631666290491844" P_Q="0.8120407759329173" P_Z="0.0011155001663284442" Q="0.4164096800178848" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="687" TOTAL_2="514" WEIGHT="100.0" Z="3.2596493903492356">
<NAME>Stroke ipsilateral to endarterectomy site</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2978420704935236" CI_END="1.746266185718489" CI_START="0.08555226055920152" DF="1.0" EFFECT_SIZE="0.3865191065475434" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.24211044451129973" LOG_CI_START="-1.067768510548168" LOG_EFFECT_SIZE="-0.4128290330184341" NO="1" P_CHI2="0.5852385085393702" P_Z="0.21667158326370395" STUDIES="3" TAU2="0.0" TOTAL_1="175" TOTAL_2="174" WEIGHT="22.06337335989717" Z="1.235427187166151">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="2.358748859246266" CI_START="0.0898748839077009" EFFECT_SIZE="0.4604261937511594" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.372681703136667" LOG_CI_START="-1.0463616575912857" LOG_EFFECT_SIZE="-0.3368399772273093" ORDER="78470" O_E="-1.116279069767442" SE="0.8335530944695226" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="1.4392408058409951" WEIGHT="18.799353372624957"/>
<DICH_DATA CI_END="7.116970904304022" CI_START="0.0027971650222280136" EFFECT_SIZE="0.14109338070134148" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8522951903420245" LOG_CI_START="-2.5532819111297607" LOG_EFFECT_SIZE="-0.8504933603938682" ORDER="78471" O_E="-0.48936170212765956" SE="2.0004528472830594" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.24988682661837933" WEIGHT="3.264019987272215"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78472" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.191371592750335" CI_START="0.05357433924831351" DF="0.0" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" NO="2" P_CHI2="1.0" P_Z="0.5834273459936132" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="51" WEIGHT="9.594746351982959" Z="0.5483853354690233">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="5.191371592750335" CI_START="0.05357433924831351" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" ORDER="78473" O_E="-0.47" SE="1.1667773095085603" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.7345545454545456" WEIGHT="9.594746351982959"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.27827090550054245" CI_END="0.6248542950239637" CI_START="0.11259536283384783" DF="2.0" EFFECT_SIZE="0.26524648172315385" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-0.20422124064674335" LOG_CI_START="-0.9484794952496945" LOG_EFFECT_SIZE="-0.5763503679482189" NO="3" P_CHI2="0.8701101706060022" P_Z="0.0024007731774170057" STUDIES="3" TAU2="0.0" TOTAL_1="463" TOTAL_2="289" WEIGHT="68.34188028811987" Z="3.0355752366026594">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.9043331039534062" CI_START="0.07204208951961158" EFFECT_SIZE="0.2552450713149218" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="-0.04367157111484767" LOG_CI_START="-1.1424136993272842" LOG_EFFECT_SIZE="-0.5930426352210658" ORDER="78474" O_E="-3.2781954887218046" SE="0.6454065649732366" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="2.400674296918478" WEIGHT="31.357590930710757"/>
<DICH_DATA CI_END="1.375472863397303" CI_START="0.022004462815382684" EFFECT_SIZE="0.1739728182107593" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.1384520266464122" LOG_CI_START="-1.6574892291988645" LOG_EFFECT_SIZE="-0.7595186012762262" ORDER="78475" O_E="-1.5714285714285716" SE="1.054944783736109" STUDY_ID="STD-Lord-1989" TOTAL_1="90" TOTAL_2="50" VAR="0.8985464689472913" WEIGHT="11.736807713420763"/>
<DICH_DATA CI_END="1.3860537792542247" CI_START="0.08265745999947369" EFFECT_SIZE="0.3384784850117144" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.14178008134377829" LOG_CI_START="-1.0827179443865302" LOG_EFFECT_SIZE="-0.47046893152137603" ORDER="78476" O_E="-2.093896713615023" SE="0.719276201676967" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="1.932896579286746" WEIGHT="25.247481643988355"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4733901691030336" CI_END="2.0862410025757336" CI_START="0.18487387954805368" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.6210406329849898" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.3193644766902336" LOG_CI_START="-0.7331244450846905" LOG_EFFECT_SIZE="-0.20687998419722856" METHOD="PETO" MODIFIED="2009-05-05 16:12:45 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6884253663676163" P_Q="0.4786935163978542" P_Z="0.4409966447777579" Q="1.473389833779526" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="986" TOTAL_2="883" WEIGHT="99.99999999999997" Z="0.7705113275016404">
<NAME>Death from all causes</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="17.5688613313287" CI_START="0.1823097218380459" DF="0.0" EFFECT_SIZE="1.7896855093355748" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="1.2447436150214424" LOG_CI_START="-0.7391901715642203" LOG_EFFECT_SIZE="0.2527767217286111" NO="1" P_CHI2="1.0" P_Z="0.6174656663746969" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="28.14366932552873" Z="0.4994453686590202">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="17.5688613313287" CI_START="0.1823097218380459" EFFECT_SIZE="1.7896855093355748" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2447436150214424" LOG_CI_START="-0.7391901715642203" LOG_EFFECT_SIZE="0.2527767217286111" ORDER="78477" O_E="0.4285714285714286" SE="1.165372526871047" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="0.736326530612245" WEIGHT="28.14366932552873"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78478" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78479" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.151522800280241" CI_START="0.0028095450279794904" DF="0.0" EFFECT_SIZE="0.1417481051937179" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.8543985275832571" LOG_CI_START="-2.5513640031681852" LOG_EFFECT_SIZE="-0.8484827377924641" MODIFIED="2009-05-05 10:51:00 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3287783523538863" STUDIES="3" TAU2="0.0" TOTAL_1="402" TOTAL_2="435" WEIGHT="9.550065278047551" Z="0.9765775461803857">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-05 10:51:00 +0100" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.0" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="153" TOTAL_2="175" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78480" O_E="0.0" SE="0.0" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.151522800280241" CI_START="0.0028095450279794904" EFFECT_SIZE="0.1417481051937179" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8543985275832571" LOG_CI_START="-2.5513640031681852" LOG_EFFECT_SIZE="-0.8484827377924641" MODIFIED="2009-05-05 10:30:07 +0100" MODIFIED_BY="[Empty name]" ORDER="99" O_E="-0.4881516587677725" SE="2.0005617693598197" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="0.2498596168100447" WEIGHT="9.550065278047551"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.353235077374877E-7" CI_END="2.241416356234464" CI_START="0.10402781744577677" DF="1.0" EFFECT_SIZE="0.4828764350497309" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.3505225367759327" LOG_CI_START="-0.9828505131261325" LOG_EFFECT_SIZE="-0.3161639881750999" MODIFIED="2009-05-05 16:12:45 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9995379680708191" P_Z="0.3526417647523069" STUDIES="3" TAU2="0.0" TOTAL_1="410" TOTAL_2="276" WEIGHT="62.3062653964237" Z="0.9294773583090756">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="3.8631028710835955" CI_START="0.06040815427587313" EFFECT_SIZE="0.48307650969591376" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.586936273184712" LOG_CI_START="-1.2189044335976191" LOG_EFFECT_SIZE="-0.3159840802064536" ORDER="78481" O_E="-0.6466165413533833" SE="1.060759770219607" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="0.8887219749604487" WEIGHT="33.96848591727458"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-05-05 16:12:45 +0100" MODIFIED_BY="[Empty name]" ORDER="114" O_E="0.0" SE="0.0" STUDY_ID="STD-Pratesi-1986" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.700932210729061" CI_START="0.0495514906552509" EFFECT_SIZE="0.48263671483933857" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6721839885380565" LOG_CI_START="-1.3049432761209423" LOG_EFFECT_SIZE="-0.3163796437914429" ORDER="78482" O_E="-0.5401069518716577" SE="1.1613743421984977" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="0.74140506015005" WEIGHT="28.337779479149123"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.859194938731639" CI_END="1.0131689359348495" CI_START="0.332616995842609" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5805146059761997" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="31" I2="0.0" I2_Q="44.713100078473" ID="CMP-001.05" LOG_CI_END="0.0056818657228366745" LOG_CI_START="-0.4780555632581793" LOG_EFFECT_SIZE="-0.23618684876767126" METHOD="PETO" MODIFIED="2009-05-05 10:51:53 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5619953614474096" P_Q="0.16385943347777465" P_Z="0.055630195054707406" Q="3.6174934800807343" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="936" TOTAL_2="833" WEIGHT="100.0" Z="1.913921435361212">
<NAME>Any stroke or death</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5267980681299619" CI_END="2.254244674886223" CI_START="0.13239297536015318" DF="1.0" EFFECT_SIZE="0.5463022603815293" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.35300105243146124" LOG_CI_START="-0.8781350575191029" LOG_EFFECT_SIZE="-0.2625670025438208" NO="1" P_CHI2="0.46795621052218483" P_Z="0.4031485371777359" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="15.4385761710707" Z="0.8360113302747494">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="3.062220649260305" CI_START="0.14641951420680038" EFFECT_SIZE="0.6696035094432575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4860364807135454" LOG_CI_START="-0.8344010383899505" LOG_EFFECT_SIZE="-0.1741822788382026" ORDER="78483" O_E="-0.6666666666666665" SE="0.7756315349925287" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="1.6622222222222225" WEIGHT="13.420962787966738"/>
<DICH_DATA CI_END="7.116970904304022" CI_START="0.0027971650222280136" EFFECT_SIZE="0.14109338070134148" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8522951903420245" LOG_CI_START="-2.5532819111297607" LOG_EFFECT_SIZE="-0.8504933603938682" ORDER="78484" O_E="-0.48936170212765956" SE="2.0004528472830594" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.24988682661837933" WEIGHT="2.0176133831039627"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78485" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5798079261292006" CI_END="2.6860090997996204" CI_START="0.4534800507929875" DF="2.0" EFFECT_SIZE="1.1036537242303668" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.4291074796603463" LOG_CI_START="-0.3434418133912905" LOG_EFFECT_SIZE="0.04283283313452791" MODIFIED="2009-05-05 10:51:53 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7483354584791142" P_Z="0.8279476662983886" STUDIES="3" TAU2="0.0" TOTAL_1="402" TOTAL_2="435" WEIGHT="39.207304462717154" Z="0.2173345081137167">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="3.6442624006446778" CI_START="0.3626680439813911" EFFECT_SIZE="1.1496336445132134" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5616096402683559" LOG_CI_START="-0.4404907100218888" LOG_EFFECT_SIZE="0.06055946512323352" MODIFIED="2009-05-05 10:51:53 +0100" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.4024390243902438" SE="0.5886387062372253" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="153" TOTAL_2="175" VAR="2.8860401464833627" WEIGHT="23.302201650720686"/>
<DICH_DATA CI_END="5.10906223973841" CI_START="0.052381715424602196" EFFECT_SIZE="0.5173214129809031" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7083411933869612" LOG_CI_START="-1.2808202831685205" LOG_EFFECT_SIZE="-0.2862395448907797" ORDER="78486" O_E="-0.48275862068965525" SE="1.1684432978368013" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.732461355529132" WEIGHT="5.9139725511779"/>
<DICH_DATA CI_END="9.151029168976526" CI_START="0.2698230304400663" EFFECT_SIZE="1.5713556001168825" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9614699396700256" LOG_CI_START="-0.5689209843669684" LOG_EFFECT_SIZE="0.1962744776515286" MODIFIED="2009-05-05 10:30:50 +0100" MODIFIED_BY="[Empty name]" ORDER="100" O_E="0.5592417061611372" SE="0.8989592043365813" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="1.2374282685248057" WEIGHT="9.991130260818565"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.13509546439174192" CI_END="0.7775617626602014" CI_START="0.148745011875236" DF="1.0" EFFECT_SIZE="0.3400859209385491" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="16" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="-0.10926510440120694" LOG_CI_START="-0.8275575893061896" LOG_EFFECT_SIZE="-0.4684113468536983" NO="3" P_CHI2="0.7132064031910595" P_Z="0.010580555716686656" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="45.35411936621213" Z="2.556254977120058">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.8846936178272345" CI_START="0.10023017526903255" EFFECT_SIZE="0.29778011413494054" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="-0.05320710571419818" LOG_CI_START="-0.9990015102058386" LOG_EFFECT_SIZE="-0.5261043079600184" ORDER="78487" O_E="-3.924812030075188" SE="0.5555643149561982" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="3.239897832767205" WEIGHT="26.159287049027043"/>
<DICH_DATA CI_END="1.45303450159052" CI_START="0.11432803479596963" EFFECT_SIZE="0.40758137722126775" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.16227592652960185" LOG_CI_START="-0.9418472616057076" LOG_EFFECT_SIZE="-0.38978566753805294" ORDER="78488" O_E="-2.1336898395721926" SE="0.6485674262086084" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="2.3773314428724435" WEIGHT="19.194832317185092"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9941094217621917" CI_END="0.4108645219193695" CI_START="0.07883049389507875" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.17996847831459073" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-0.38630135837274404" LOG_CI_START="-1.10330575245227" LOG_EFFECT_SIZE="-0.744803555412507" METHOD="PETO" MODIFIED="2009-05-05 10:52:34 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9630395024809307" P_Q="0.7299702392717369" P_Z="4.662949719327762E-5" Q="0.6295031539775503" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="794" TOTAL_2="641" WEIGHT="100.00000000000001" Z="4.071908502150644">
<NAME>Occlusion of the artery operated on</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.989261147290223" CI_START="0.0075832025000867305" DF="0.0" EFFECT_SIZE="0.12282088627532625" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="0.2986918004106678" LOG_CI_START="-2.12014734655913" LOG_EFFECT_SIZE="-0.9107277730742309" NO="1" P_CHI2="1.0" P_Z="0.1399682339257937" STUDIES="2" TAU2="0.0" TOTAL_1="129" TOTAL_2="126" WEIGHT="8.786778061005" Z="1.4759093321124823">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="1.989261147290223" CI_START="0.0075832025000867305" EFFECT_SIZE="0.12282088627532625" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.2986918004106678" LOG_CI_START="-2.12014734655913" LOG_EFFECT_SIZE="-0.9107277730742309" ORDER="78489" O_E="-1.0387596899224807" SE="1.4208380883769418" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="0.4953484616309116" WEIGHT="8.786778061005"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78490" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.23384114758096997" CI_END="1.9464809988769936" CI_START="0.0572982491527408" DF="1.0" EFFECT_SIZE="0.3339610055750967" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.2892501685868552" LOG_CI_START="-1.2418586484500729" LOG_EFFECT_SIZE="-0.47630423993160875" MODIFIED="2009-05-05 10:52:34 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6286902107022068" P_Z="0.22268147637361724" STUDIES="2" TAU2="0.0" TOTAL_1="202" TOTAL_2="226" WEIGHT="21.929640871111644" Z="1.2194288812944147">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="2.991099764811795" CI_START="0.05777026574889693" EFFECT_SIZE="0.41568813826550366" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4758308986831655" LOG_CI_START="-1.2382956346567169" LOG_EFFECT_SIZE="-0.38123236798677573" MODIFIED="2009-05-05 10:52:34 +0100" MODIFIED_BY="[Empty name]" ORDER="108" O_E="-0.8658536585365855" SE="1.0068864107470323" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="153" TOTAL_2="175" VAR="0.9863681513297569" WEIGHT="17.496769857006687"/>
<DICH_DATA CI_END="7.098815053335594" CI_START="0.0027906059965388348" EFFECT_SIZE="0.14074798704123073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.851185861571808" LOG_CI_START="-2.5543014768786776" LOG_EFFECT_SIZE="-0.8515578076534348" ORDER="78491" O_E="-0.49" SE="2.000400120040014" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.24990000000000004" WEIGHT="4.432871014104958"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.13076512020367148" CI_END="0.41875101837011114" CI_START="0.05761722441415193" DF="2.0" EFFECT_SIZE="0.1553295573903607" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="-0.378044123783201" LOG_CI_START="-1.2394476667541774" LOG_EFFECT_SIZE="-0.8087458952686892" NO="3" P_CHI2="0.9367090567448018" P_Z="2.3295738753552542E-4" STUDIES="3" TAU2="0.0" TOTAL_1="463" TOTAL_2="289" WEIGHT="69.28358106788338" Z="3.6803025488011984">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.8803997331848834" CI_START="0.037530041779677996" EFFECT_SIZE="0.18177304192108917" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="-0.05532009773653424" LOG_CI_START="-1.4256209521157344" LOG_EFFECT_SIZE="-0.7404705249261342" ORDER="78492" O_E="-2.6315789473684212" SE="0.8049215049609677" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="1.543451328665488" WEIGHT="27.378634079723987"/>
<DICH_DATA CI_END="1.375472863397303" CI_START="0.022004462815382684" EFFECT_SIZE="0.1739728182107593" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.1384520266464122" LOG_CI_START="-1.6574892291988645" LOG_EFFECT_SIZE="-0.7595186012762262" ORDER="78493" O_E="-1.5714285714285716" SE="1.054944783736109" STUDY_ID="STD-Lord-1989" TOTAL_1="90" TOTAL_2="50" VAR="0.8985464689472913" WEIGHT="15.938937963276539"/>
<DICH_DATA CI_END="0.620279511465093" CI_START="0.024294393322612507" EFFECT_SIZE="0.12275713592899966" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="-0.20741256383681858" LOG_CI_START="-1.6144939416279933" LOG_EFFECT_SIZE="-0.910953252732406" ORDER="78494" O_E="-3.0704225352112675" SE="0.8265265664796889" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="1.4638155801671577" WEIGHT="25.966009024882847"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.121190247097712" CI_END="2.542869218197171" CI_START="0.6072570174846491" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.2426484528199984" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.4053240246366387" LOG_CI_START="-0.21662745777066966" LOG_EFFECT_SIZE="0.09434828343298453" METHOD="PETO" MODIFIED="2009-05-05 10:53:19 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5321029824567447" P_Q="0.37496182665593947" P_Z="0.552082800430183" Q="1.9618626063035642" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1090" TOTAL_2="941" WEIGHT="100.00000000000001" Z="0.5946420026722451">
<NAME>Rupture/haemorrhage of endarterectomy site</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="346.626872389393" CI_START="0.13567368694309764" DF="0.0" EFFECT_SIZE="6.857707034470309" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="2.5398622285395716" LOG_CI_START="-0.8675043728524228" LOG_EFFECT_SIZE="0.8361789278435743" NO="1" P_CHI2="1.0" P_Z="0.33606811843960394" STUDIES="3" TAU2="0.0" TOTAL_1="219" TOTAL_2="210" WEIGHT="3.3317721236578706" Z="0.9619631668251951">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="346.6268723893933" CI_START="0.13567368694309753" EFFECT_SIZE="6.857707034470309" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.539862228539572" LOG_CI_START="-0.867504372852423" LOG_EFFECT_SIZE="0.8361789278435743" ORDER="78495" O_E="0.48062015503875966" SE="2.001504008394358" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="0.2496244216092783" WEIGHT="3.3317721236578706"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78496" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78497" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="90" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8942443888604352" CI_END="2.143960260221655" CI_START="0.3926228762555275" DF="2.0" EFFECT_SIZE="0.9174790700314506" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.3312167311483454" LOG_CI_START="-0.40602439973829685" LOG_EFFECT_SIZE="-0.03740383429497573" MODIFIED="2009-05-05 10:53:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.38785565979476855" P_Z="0.8423589278212656" STUDIES="3" TAU2="0.0" TOTAL_1="408" TOTAL_2="442" WEIGHT="71.16949780433667" Z="0.19887704315598947">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="2.157191849505665" CI_START="0.2341935201170988" EFFECT_SIZE="0.7107744739392703" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.33388877072914097" LOG_CI_START="-0.6304251255587865" LOG_EFFECT_SIZE="-0.14826817741482282" MODIFIED="2009-05-05 10:53:19 +0100" MODIFIED_BY="[Empty name]" ORDER="109" O_E="-1.0640243902439028" SE="0.5664427561103001" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="153" TOTAL_2="175" VAR="3.1166493670488844" WEIGHT="41.598355695352595"/>
<DICH_DATA CI_END="7.098815053335594" CI_START="0.0027906059965388348" EFFECT_SIZE="0.14074798704123073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.851185861571808" LOG_CI_START="-2.5543014768786776" LOG_EFFECT_SIZE="-0.8515578076534348" ORDER="78498" O_E="-0.49" SE="2.000400120040014" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.24990000000000004" WEIGHT="3.3354503070430135"/>
<DICH_DATA CI_END="7.06339212536075" CI_START="0.431278042695109" EFFECT_SIZE="1.745361260774866" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8490133168491063" LOG_CI_START="-0.36524265216959473" LOG_EFFECT_SIZE="0.24188533233975584" MODIFIED="2009-05-05 10:31:44 +0100" MODIFIED_BY="[Empty name]" ORDER="101" O_E="1.09478672985782" SE="0.7132599668655704" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="1.9656414510091877" WEIGHT="26.23569180194105"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2650832519337128" CI_END="9.5717183511104" CI_START="0.5614508928497216" DF="1.0" EFFECT_SIZE="2.31819969250645" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-001.07.03" LOG_CI_END="0.9809899109654084" LOG_CI_START="-0.25068822319066103" LOG_EFFECT_SIZE="0.3651508438873737" NO="3" P_CHI2="0.6066492497408638" P_Z="0.24518436624237594" STUDIES="3" TAU2="0.0" TOTAL_1="463" TOTAL_2="289" WEIGHT="25.498730072005472" Z="1.1621258559307572">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="85.45391204265324" CI_START="0.24228610602394826" EFFECT_SIZE="4.550197313669752" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9317319493229632" LOG_CI_START="-0.6156714899076474" LOG_EFFECT_SIZE="0.6580302297076579" ORDER="78499" O_E="0.6766917293233083" SE="1.496357390054454" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="0.44661091653075713" WEIGHT="5.96097846607153"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78500" O_E="0.0" SE="0.0" STUDY_ID="STD-Lord-1989" TOTAL_1="90" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.535289331989654" CI_START="0.37346722758761364" EFFECT_SIZE="1.8870924913909028" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9793338755026462" LOG_CI_START="-0.4277475022885287" LOG_EFFECT_SIZE="0.27579318660705876" ORDER="78501" O_E="0.9295774647887325" SE="0.8265265664796889" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="1.4638155801671577" WEIGHT="19.53775160593394"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.586975725626248" CI_END="1.535582446811758" CI_START="0.09431653104162327" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.38056643245521926" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="61.34482476607225" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.18627313906899087" LOG_CI_START="-1.0254121809535317" LOG_EFFECT_SIZE="-0.4195695209422705" METHOD="PETO" MODIFIED="2009-05-05 10:33:22 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.10774627623153699" P_Q="1.0" P_Z="0.1746697046156918" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="847" TOTAL_2="716" WEIGHT="100.0" Z="1.3573510159259643">
<NAME>Infection of the endarterectomy site</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="219" TOTAL_2="210" WEIGHT="0.0" Z="0.0">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78502" O_E="0.0" SE="0.0" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78503" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78504" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="90" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.586975725626248" CI_END="1.535582446811758" CI_START="0.09431653104162327" DF="1.0" EFFECT_SIZE="0.38056643245521926" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="61.34482476607225" ID="CMP-001.08.02" LOG_CI_END="0.18627313906899087" LOG_CI_START="-1.0254121809535317" LOG_EFFECT_SIZE="-0.4195695209422705" MODIFIED="2009-05-05 10:33:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.10774627623153699" P_Z="0.1746697046156918" STUDIES="2" TAU2="0.0" TOTAL_1="255" TOTAL_2="267" WEIGHT="100.0" Z="1.3573510159259643">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="388.20304572966427" CI_START="0.15260599679643835" EFFECT_SIZE="7.6968898103707275" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.589058938415553" LOG_CI_START="-0.8164284000349331" LOG_EFFECT_SIZE="0.8863152691903097" ORDER="78505" O_E="0.51" SE="2.000400120040014" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.24990000000000004" WEIGHT="12.659634078242847"/>
<DICH_DATA CI_END="1.0949956694037246" CI_START="0.05532011582281677" EFFECT_SIZE="0.24612047305516216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.03941240158911902" LOG_CI_START="-1.2571169192865603" LOG_EFFECT_SIZE="-0.6088522588487207" MODIFIED="2009-05-05 10:33:22 +0100" MODIFIED_BY="[Empty name]" ORDER="102" O_E="-2.4170616113744074" SE="0.7615877410060193" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="1.7240907050669356" WEIGHT="87.34036592175715"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="373" TOTAL_2="239" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78506" O_E="0.0" SE="0.0" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78507" O_E="0.0" SE="0.0" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.018274318791282433" CI_END="1.693228321169985" CI_START="0.3571669794185293" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7776665383943113" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.22871552393201133" LOG_CI_START="-0.4471286990533912" LOG_EFFECT_SIZE="-0.10920658756068996" METHOD="PETO" MODIFIED="2009-05-05 10:34:04 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.9909044578834314" P_Q="0.9909044578834314" P_Z="0.5264703182644904" Q="0.018274318791282433" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="581" TOTAL_2="466" WEIGHT="100.0" Z="0.6334032938773682">
<NAME>Cranial nerve palsy</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.496757196830523" CI_START="0.16771029238482227" DF="0.0" EFFECT_SIZE="0.7657951239588684" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.5436654773942922" LOG_CI_START="-0.7754402839128683" LOG_EFFECT_SIZE="-0.11588740325928809" NO="1" P_CHI2="1.0" P_Z="0.7305624487151066" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="64" WEIGHT="26.250282248991862" Z="0.34437744616473526">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="3.496757196830523" CI_START="0.16771029238482227" EFFECT_SIZE="0.7657951239588684" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5436654773942922" LOG_CI_START="-0.7754402839128683" LOG_EFFECT_SIZE="-0.11588740325928809" ORDER="78508" O_E="-0.44444444444444464" SE="0.7748492538706538" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="1.66558024691358" WEIGHT="26.250282248991862"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.347170727880947" CI_START="0.23674689915213457" DF="0.0" EFFECT_SIZE="0.7454430840825294" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.3705446803441931" LOG_CI_START="-0.6257157005609567" LOG_EFFECT_SIZE="-0.12758551010838173" MODIFIED="2009-05-05 10:34:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6156651940441856" STUDIES="2" TAU2="0.0" TOTAL_1="255" TOTAL_2="267" WEIGHT="46.02009303203212" Z="0.5020033106895312">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78509" O_E="0.0" SE="0.0" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.347170727880947" CI_START="0.23674689915213457" EFFECT_SIZE="0.7454430840825294" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3705446803441931" LOG_CI_START="-0.6257157005609567" LOG_EFFECT_SIZE="-0.12758551010838173" MODIFIED="2009-05-05 10:34:04 +0100" MODIFIED_BY="[Empty name]" ORDER="103" O_E="-0.8578199052132698" SE="0.5852082793121057" STUDY_ID="STD-Mannheim-2005" TOTAL_1="206" TOTAL_2="216" VAR="2.919974619252779" WEIGHT="46.02009303203212"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.7096937653357247" CI_START="0.19315275149210906" DF="0.0" EFFECT_SIZE="0.8464854150945057" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-001.09.03" LOG_CI_END="0.5693380601503255" LOG_CI_START="-0.7140991008801304" LOG_EFFECT_SIZE="-0.07238052036490236" NO="3" P_CHI2="1.0" P_Z="0.8250397654426426" STUDIES="1" TAU2="0.0" TOTAL_1="264" TOTAL_2="135" WEIGHT="27.72962471897601" Z="0.22106764149415206">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="3.7096937653357247" CI_START="0.19315275149210906" EFFECT_SIZE="0.8464854150945057" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.5693380601503255" LOG_CI_START="-0.7140991008801304" LOG_EFFECT_SIZE="-0.07238052036490236" ORDER="78510" O_E="-0.2932330827067666" SE="0.7538973415056986" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="1.759444517516635" WEIGHT="27.72962471897601"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.672115812268841" CI_END="0.7873472900298106" CI_START="0.15574072069400333" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.35017429144029577" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="11.849472657364442" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-0.10383366297153573" LOG_CI_START="-0.807597819926858" LOG_EFFECT_SIZE="-0.4557157414491968" METHOD="PETO" NO="10" P_CHI2="0.3394416817198287" P_Q="0.6727348011828989" P_Z="0.01113886874991827" Q="0.7928088053714459" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="731" TOTAL_2="550" WEIGHT="100.00000000000003" Z="2.538311823928527">
<NAME>Complication with return to theatre</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.89386100448107" CI_END="15.644466947051965" CI_START="0.061058012788662984" DF="1.0" EFFECT_SIZE="0.9773536017864333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="47.197814536869544" ID="CMP-001.10.01" LOG_CI_END="1.1943607700454704" LOG_CI_START="-1.2142573344782706" LOG_EFFECT_SIZE="-0.009948282216400131" NO="1" P_CHI2="0.16876730459346223" P_Z="0.9870824745602892" STUDIES="3" TAU2="0.0" TOTAL_1="219" TOTAL_2="210" WEIGHT="8.537257791780611" Z="0.016190424555527407">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="346.6268723893933" CI_START="0.13567368694309753" EFFECT_SIZE="6.857707034470309" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.539862228539572" LOG_CI_START="-0.867504372852423" LOG_EFFECT_SIZE="0.8361789278435743" ORDER="78511" O_E="0.48062015503875966" SE="2.001504008394358" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="0.2496244216092783" WEIGHT="4.265957889664334"/>
<DICH_DATA CI_END="7.0404485350121435" CI_START="0.002769269033306606" EFFECT_SIZE="0.13963128628139893" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8476003281869293" LOG_CI_START="-2.5576348506809836" LOG_EFFECT_SIZE="-0.8550172612470271" ORDER="78512" O_E="-0.49206349206349204" SE="2.0002520002530004" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.2499370118417737" WEIGHT="4.271299902116277"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78513" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="90" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.191371592750335" CI_START="0.05357433924831351" DF="0.0" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" NO="2" P_CHI2="1.0" P_Z="0.5834273459936132" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="51" WEIGHT="12.553173837595965" Z="0.5483853354690233">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="5.191371592750335" CI_START="0.05357433924831351" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" ORDER="78514" O_E="-0.47" SE="1.1667773095085603" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.7345545454545456" WEIGHT="12.553173837595965"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.985446002416325" CI_END="0.7309555871444735" CI_START="0.11793450161802725" DF="2.0" EFFECT_SIZE="0.29360668056908373" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="33.008334487334096" ID="CMP-001.10.03" LOG_CI_END="-0.13610900996969913" LOG_CI_START="-0.9283591239095301" LOG_EFFECT_SIZE="-0.5322340669396146" NO="3" P_CHI2="0.22475986511123291" P_Z="0.008453228832940956" STUDIES="3" TAU2="0.0" TOTAL_1="463" TOTAL_2="289" WEIGHT="78.90956837062345" Z="2.633409788631851">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.5842959094140312" CI_START="0.019427773457802888" EFFECT_SIZE="0.10654374012778373" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="-0.23336715412295614" LOG_CI_START="-1.711576969364111" LOG_EFFECT_SIZE="-0.9724720617435336" ORDER="78515" O_E="-2.969924812030075" SE="0.868307762729251" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="1.3263331752890746" WEIGHT="22.666377900733693"/>
<DICH_DATA CI_END="1.375472863397303" CI_START="0.022004462815382684" EFFECT_SIZE="0.1739728182107593" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.1384520266464122" LOG_CI_START="-1.6574892291988645" LOG_EFFECT_SIZE="-0.7595186012762262" ORDER="78516" O_E="-1.5714285714285716" SE="1.054944783736109" STUDY_ID="STD-Lord-1989" TOTAL_1="90" TOTAL_2="50" VAR="0.8985464689472913" WEIGHT="15.355714692192805"/>
<DICH_DATA CI_END="2.2257605608340074" CI_START="0.1765517972875226" EFFECT_SIZE="0.6268668338227253" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.34747844270236533" LOG_CI_START="-0.7531278569845972" LOG_EFFECT_SIZE="-0.20282470714111586" ORDER="78517" O_E="-1.117370892018779" SE="0.6465015885251709" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="2.3925488146049356" WEIGHT="40.88747577769694"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2009-07-20 13:42:43 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<NAME>Patch versus no patch: outcomes at end of follow up</NAME>
<DICH_OUTCOME CHI2="9.588429597579962" CI_END="0.9046687733978834" CI_START="0.2701889232217433" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.4944001231358154" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="28" I2="47.853817467023404" I2_Q="72.45834656149655" ID="CMP-002.01" LOG_CI_END="-0.043510400039263666" LOG_CI_START="-0.5683324594675083" LOG_EFFECT_SIZE="-0.30592142975338604" METHOD="PETO" MODIFIED="2009-05-05 10:54:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.08777313311385526" P_Q="0.026493343732965302" P_Z="0.022316005098266513" Q="7.261728147388509" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="723" TOTAL_2="609" WEIGHT="100.00000000000001" Z="2.284945815992764">
<NAME>Any stroke: fatal and non-fatal</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4555172563374187" CI_END="1.2975464812583395" CI_START="0.13899411831417932" DF="1.0" EFFECT_SIZE="0.4246779122278067" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.11312292427960051" LOG_CI_START="-0.8570035769958416" LOG_EFFECT_SIZE="-0.3719403263581205" NO="1" P_CHI2="0.4997265046537055" P_Z="0.13287116856067402" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="29.266273386489253" Z="1.5028754355263458">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="1.3036815988901593" CI_START="0.07495362908831879" EFFECT_SIZE="0.31259505276392235" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.11517153562146809" LOG_CI_START="-1.1252073347319778" LOG_EFFECT_SIZE="-0.5050178995552548" ORDER="78518" O_E="-2.1904761904761907" SE="0.7286046884200467" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="1.8837188208616782" WEIGHT="17.90257258489788"/>
<DICH_DATA CI_END="4.131874393423787" CI_START="0.11462456476319016" EFFECT_SIZE="0.6881964138255676" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6161471107488222" LOG_CI_START="-0.9407223003627398" LOG_EFFECT_SIZE="-0.16228759480695884" ORDER="78519" O_E="-0.44680851063829774" SE="0.9145127987148075" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="1.1956950305933205" WEIGHT="11.363700801591373"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78520" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7716383690965734" CI_END="6.450022473398211" CI_START="0.58805499704628" DF="1.0" EFFECT_SIZE="1.9475543500869559" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="43.55507210481456" ID="CMP-002.01.02" LOG_CI_END="0.8095612278222181" LOG_CI_START="-0.23058205522184885" LOG_EFFECT_SIZE="0.2894895863001846" MODIFIED="2009-05-05 10:54:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.18317957338954616" P_Z="0.2752805125060497" STUDIES="2" TAU2="0.0" TOTAL_1="189" TOTAL_2="211" WEIGHT="25.458793853124057" Z="1.0909826988205888">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="13.070332895676232" CI_START="0.7870834910335508" EFFECT_SIZE="3.2074044404314694" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.11628664901238" LOG_CI_START="-0.10397919677442796" LOG_EFFECT_SIZE="0.506153726118976" MODIFIED="2009-05-05 10:54:56 +0100" MODIFIED_BY="[Empty name]" ORDER="110" O_E="2.268370607028754" SE="0.7167901982285262" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="146" TOTAL_2="167" VAR="1.9463273442593432" WEIGHT="18.497594316457185"/>
<DICH_DATA CI_END="5.10906223973841" CI_START="0.052381715424602196" EFFECT_SIZE="0.5173214129809031" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7083411933869612" LOG_CI_START="-1.2808202831685205" LOG_EFFECT_SIZE="-0.2862395448907797" ORDER="78521" O_E="-0.48275862068965525" SE="1.1684432978368013" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.732461355529132" WEIGHT="6.96119953666687"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.09954582475746088" CI_END="0.6193482647586767" CI_START="0.10279108513783888" DF="1.0" EFFECT_SIZE="0.25231623057738856" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="-0.20806507484008113" LOG_CI_START="-0.9880445491863649" LOG_EFFECT_SIZE="-0.598054812013223" NO="3" P_CHI2="0.7523753693796479" P_Z="0.0026502895661259115" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="45.274932760386704" Z="3.0056326631138726">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.7440965234196191" CI_START="0.06581206617854889" EFFECT_SIZE="0.22129285944765623" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.12837072457574103" LOG_CI_START="-1.1816944742530908" LOG_EFFECT_SIZE="-0.6550325994144158" ORDER="78522" O_E="-3.93984962406015" SE="0.6187275845971271" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="2.6121676276685593" WEIGHT="24.825637478562307"/>
<DICH_DATA CI_END="1.1256512415063984" CI_START="0.0777731455884473" EFFECT_SIZE="0.2958807832345548" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.05140385467984165" LOG_CI_START="-1.1091703353501607" LOG_EFFECT_SIZE="-0.5288832403351595" ORDER="78523" O_E="-2.620320855614973" SE="0.6817270241585172" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="2.151686424565906" WEIGHT="20.449295281824394"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.4937477670373758" CI_END="1.5984311111547786" CI_START="0.046852535388579204" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.2736613787175407" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.20369392387950166" LOG_CI_START="-1.3292669026315675" LOG_EFFECT_SIZE="-0.562786489376033" METHOD="PETO" NO="2" P_CHI2="0.4822603060768055" P_Q="0.4822603060768055" P_Z="0.15012245539767952" Q="0.4937477670373758" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="577" TOTAL_2="442" WEIGHT="100.0" Z="1.4390990703568298">
<NAME>Stroke-related death</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.517844349070566" CI_START="0.04688106594124683" DF="0.0" EFFECT_SIZE="0.46021881626142425" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.65493126432135" LOG_CI_START="-1.3290025222643127" LOG_EFFECT_SIZE="-0.3370356289714814" NO="1" P_CHI2="1.0" P_Z="0.5054576648106671" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="59.704596392323445" Z="0.6659271582120267">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="4.517844349070566" CI_START="0.04688106594124683" EFFECT_SIZE="0.46021881626142425" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.65493126432135" LOG_CI_START="-1.3290025222643127" LOG_EFFECT_SIZE="-0.3370356289714814" ORDER="78524" O_E="-0.5714285714285714" SE="1.165372526871047" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="0.736326530612245" WEIGHT="59.704596392323445"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78525" O_E="0.0" SE="0.0" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78526" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78527" O_E="0.0" SE="0.0" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0426134167459384" CI_START="0.007857114855076437" DF="0.0" EFFECT_SIZE="0.126684838161056" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-002.02.03" LOG_CI_END="0.31018618021028244" LOG_CI_START="-2.104736898304598" LOG_EFFECT_SIZE="-0.8972753590471579" NO="3" P_CHI2="1.0" P_Z="0.14526367961823036" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="40.295403607676555" Z="1.4564665877715566">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78528" O_E="0.0" SE="0.0" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.0426134167459384" CI_START="0.007857114855076437" EFFECT_SIZE="0.126684838161056" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.31018618021028244" LOG_CI_START="-2.104736898304598" LOG_EFFECT_SIZE="-0.8972753590471579" ORDER="78529" O_E="-1.0267379679144386" SE="1.4185377703816722" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="0.4969562903179684" WEIGHT="40.295403607676555"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7675222197369791" CI_END="0.6334222420891131" CI_START="0.15723080573691378" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.31558436193093237" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.19830669081101054" LOG_CI_START="-0.8034623600088393" LOG_EFFECT_SIZE="-0.500884525409925" METHOD="PETO" NO="3" P_CHI2="0.9427483743241645" P_Q="0.7407850644927294" P_Z="0.001176544972010028" Q="0.600089604597449" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="641" TOTAL_2="500" WEIGHT="100.00000000000001" Z="3.2445061004492124">
<NAME>Stroke ipsilateral to endarterectomy site</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.05796393453226123" CI_END="1.4704243935303163" CI_START="0.11729937265740004" DF="1.0" EFFECT_SIZE="0.4153069454045333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.1674426988079065" LOG_CI_START="-0.9307043105797648" LOG_EFFECT_SIZE="-0.3816308058859292" NO="1" P_CHI2="0.8097434582648255" P_Z="0.17311483379108486" STUDIES="3" TAU2="0.0" TOTAL_1="219" TOTAL_2="210" WEIGHT="30.367794089550216" Z="1.3622632098128542">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="1.7102258770697838" CI_START="0.08201650459273628" EFFECT_SIZE="0.3745220267238102" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2330534733668017" LOG_CI_START="-1.0860987435639482" LOG_EFFECT_SIZE="-0.4265226350985732" ORDER="78530" O_E="-1.635658914728682" SE="0.7748765421339093" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="1.6654629379244037" WEIGHT="21.04477995183143"/>
<DICH_DATA CI_END="5.136527931806799" CI_START="0.05354720535673883" EFFECT_SIZE="0.524448964137678" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7106696540965314" LOG_CI_START="-1.2712631901882092" LOG_EFFECT_SIZE="-0.28029676804583903" ORDER="78531" O_E="-0.4761904761904763" SE="1.1641971634586612" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.737814058956916" WEIGHT="9.323014137718785"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78532" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="90" TOTAL_2="84" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.191371592750335" CI_START="0.05357433924831351" DF="0.0" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" NO="2" P_CHI2="1.0" P_Z="0.5834273459936132" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="51" WEIGHT="9.281826944149111" Z="0.5483853354690233">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="5.191371592750335" CI_START="0.05357433924831351" EFFECT_SIZE="0.5273749168040363" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7152821163196355" LOG_CI_START="-1.2710431765638928" LOG_EFFECT_SIZE="-0.27788053012212866" ORDER="78533" O_E="-0.47" SE="1.1667773095085603" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.7345545454545456" WEIGHT="9.281826944149111"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.10946868060726889" CI_END="0.6227316678962659" CI_START="0.10359040245536605" DF="1.0" EFFECT_SIZE="0.25398626754034465" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" ID="CMP-002.03.03" LOG_CI_END="-0.20569904845412768" LOG_CI_START="-0.9846804796656534" LOG_EFFECT_SIZE="-0.5951897640598907" NO="3" P_CHI2="0.7407498863188817" P_Z="0.0027438522849092322" STUDIES="2" TAU2="0.0" TOTAL_1="373" TOTAL_2="239" WEIGHT="60.35037896630068" Z="2.9950662616180157">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.7440965234196191" CI_START="0.06581206617854889" EFFECT_SIZE="0.22129285944765623" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="-0.12837072457574103" LOG_CI_START="-1.1816944742530908" LOG_EFFECT_SIZE="-0.6550325994144158" ORDER="78534" O_E="-3.93984962406015" SE="0.6187275845971271" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="2.6121676276685593" WEIGHT="33.00733487956944"/>
<DICH_DATA CI_END="1.1368335221915329" CI_START="0.0791412567335249" EFFECT_SIZE="0.29995071869065004" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.05569687129534243" LOG_CI_START="-1.1015970575814698" LOG_EFFECT_SIZE="-0.5229500931430637" ORDER="78535" O_E="-2.605633802816901" SE="0.6798001825195786" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="2.1639012924210155" WEIGHT="27.34304408673124"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.46700918036974" CI_END="1.1229970548889436" CI_START="0.535117283857895" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7752000604957323" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="73" I2="22.684507466338037" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.05037861730584109" LOG_CI_START="-0.2715510214367244" LOG_EFFECT_SIZE="-0.11058620206544162" METHOD="PETO" MODIFIED="2009-05-05 16:11:45 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.26339013750008533" P_Q="0.8688335934139882" P_Z="0.17812961991533424" Q="0.2812073500960164" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="723" TOTAL_2="609" WEIGHT="100.0" Z="1.3465363057711939">
<NAME>Death from all causes</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.2533975840964544" CI_END="1.4167111041361302" CI_START="0.45335340075195524" DF="1.0" EFFECT_SIZE="0.8014179914022219" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" I2="69.26290211536738" ID="CMP-002.04.01" LOG_CI_END="0.151281297903663" LOG_CI_START="-0.343563122137052" LOG_EFFECT_SIZE="-0.09614091211669455" NO="1" P_CHI2="0.07127562861980674" P_Z="0.44630850527062016" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="42.32379182577371" Z="0.761583712206143">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="2.6787138781388045" CI_START="0.593839735436232" EFFECT_SIZE="1.2612401598043532" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="17" LOG_CI_END="0.4279263277248214" LOG_CI_START="-0.2263307459394921" LOG_EFFECT_SIZE="0.10079779089266462" ORDER="78536" O_E="1.571428571428573" SE="0.3843138436951643" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="6.770612244897959" WEIGHT="24.211688112955834"/>
<DICH_DATA CI_END="1.0442859065533696" CI_START="0.18296831324681478" EFFECT_SIZE="0.4371169533082546" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="19" LOG_CI_END="0.018819416903305197" LOG_CI_START="-0.7376241155897802" LOG_EFFECT_SIZE="-0.35940234934323756" ORDER="78537" O_E="-4.1914893617021285" SE="0.444338675442314" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="5.064910410490807" WEIGHT="18.11210371281788"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78538" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7992859729785002" CI_END="2.0519145804403567" CI_START="0.39391260372295545" DF="1.0" EFFECT_SIZE="0.8990411642401901" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.3121592774848307" LOG_CI_START="-0.4046001231772489" LOG_EFFECT_SIZE="-0.04622042284620915" MODIFIED="2009-05-05 10:55:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3713069892223516" P_Z="0.8004400707934447" STUDIES="2" TAU2="0.0" TOTAL_1="189" TOTAL_2="211" WEIGHT="20.173215560054494" Z="0.2527776100183766">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="5.442038809855932" CI_START="0.3831715736755598" EFFECT_SIZE="1.444034132136761" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7357616346223816" LOG_CI_START="-0.41660671737472327" LOG_EFFECT_SIZE="0.15957745862382922" MODIFIED="2009-05-05 10:55:40 +0100" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.8019169329073481" SE="0.6769068742784399" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="146" TOTAL_2="167" VAR="2.182439186021952" WEIGHT="7.804395671495595"/>
<DICH_DATA CI_END="1.9125454394230312" CI_START="0.23240284292911928" EFFECT_SIZE="0.6666940807844585" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.2816117621818665" LOG_CI_START="-0.6337585636273299" LOG_EFFECT_SIZE="-0.17607340072273173" ORDER="78539" O_E="-1.402298850574713" SE="0.5376930605365123" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="3.4588452899986786" WEIGHT="12.368819888558898"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.133118273198768" CI_END="1.2627943943467315" CI_START="0.3763957595230819" DF="1.0" EFFECT_SIZE="0.6894276286758663" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="23" I2="53.1202740811729" ID="CMP-002.04.03" LOG_CI_END="0.10133264535378328" LOG_CI_START="-0.42435527798149686" LOG_EFFECT_SIZE="-0.16151131631385682" MODIFIED="2009-05-05 16:11:45 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.14414731498299715" P_Z="0.2284540012372449" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="37.50299261417179" Z="1.2043509048577414">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="2.088406908978383" CI_START="0.45440822000492737" EFFECT_SIZE="0.9741608009742845" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.3198151212970692" LOG_CI_START="-0.3425538210679615" LOG_EFFECT_SIZE="-0.011369349885446163" ORDER="78540" O_E="-0.1729323308270665" SE="0.3890787955243632" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="6.605791692364246" WEIGHT="23.622290334998834"/>
<DICH_DATA CI_END="1.0351830809417821" CI_START="0.14155805917825975" EFFECT_SIZE="0.38280348461356783" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.01501716526273428" LOG_CI_START="-0.8490654003574268" LOG_EFFECT_SIZE="-0.41702411754734625" ORDER="78541" O_E="-3.7272727272727266" SE="0.5075663763229655" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="3.8816315649160233" WEIGHT="13.880702279172958"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7845945364839126" CI_END="0.8449050735329795" CI_START="0.4160413257592768" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.5928873644575334" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="91" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-0.0731920820049034" LOG_CI_START="-0.380863528368902" LOG_EFFECT_SIZE="-0.2270278051869027" METHOD="PETO" NO="5" P_CHI2="0.4359420646601013" P_Q="0.734946228544096" P_Z="0.003822169241808789" Q="0.6159159901735354" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="577" TOTAL_2="442" WEIGHT="100.0" Z="2.892477198739308">
<NAME>Any stroke or death</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.193648727222365" CI_END="1.1982576527964248" CI_START="0.39855396004883886" DF="1.0" EFFECT_SIZE="0.6910646371222027" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="43" I2="54.4138499664795" ID="CMP-002.05.01" LOG_CI_END="0.0785502113393066" LOG_CI_START="-0.3995128713444424" LOG_EFFECT_SIZE="-0.16048133000256792" NO="1" P_CHI2="0.13858077266779278" P_Z="0.1882131956840915" STUDIES="3" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="41.41941599120493" Z="1.3158833567753023">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="2.0623369154187934" CI_START="0.47851489282572773" EFFECT_SIZE="0.9934077350474809" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="21" LOG_CI_END="0.3143596156297055" LOG_CI_START="-0.3201045411235376" LOG_EFFECT_SIZE="-0.002872462746916011" ORDER="78542" O_E="-0.04761904761904745" SE="0.37268738632508264" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="66" TOTAL_2="60" VAR="7.199637188208618" WEIGHT="23.51582404119511"/>
<DICH_DATA CI_END="0.990999498233904" CI_START="0.18575263738047817" EFFECT_SIZE="0.42904634998992613" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="22" LOG_CI_END="-0.003926565408066621" LOG_CI_START="-0.7310650112596783" LOG_EFFECT_SIZE="-0.3674957883338724" ORDER="78543" O_E="-4.638297872340427" SE="0.4271247224865939" STUDY_ID="STD-Myers-1994" TOTAL_1="46" TOTAL_2="48" VAR="5.4813884548547716" WEIGHT="17.903591950009822"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78544" O_E="0.0" SE="0.0" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="62" TOTAL_2="64" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.663851581757227" CI_START="0.22829572861876396" DF="0.0" EFFECT_SIZE="0.6163198919155125" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="0.22111458391467584" LOG_CI_START="-0.6415022140229253" LOG_EFFECT_SIZE="-0.21019381505412474" NO="2" P_CHI2="1.0" P_Z="0.33949237463078186" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="44" WEIGHT="12.721507089418735" Z="0.9551687568897963">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="1.663851581757227" CI_START="0.22829572861876396" EFFECT_SIZE="0.6163198919155125" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.22111458391467584" LOG_CI_START="-0.6415022140229253" LOG_EFFECT_SIZE="-0.21019381505412474" ORDER="78545" O_E="-1.8850574712643677" SE="0.5067053771305627" STUDY_ID="STD-Katz-1994" TOTAL_1="43" TOTAL_2="44" VAR="3.8948341920993523" WEIGHT="12.721507089418735"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9750298190880122" CI_END="0.8617175924277327" CI_START="0.3027134315540142" DF="1.0" EFFECT_SIZE="0.5107381809051115" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="36" I2="0.0" ID="CMP-002.05.03" LOG_CI_END="-0.0646350406086839" LOG_CI_START="-0.5189683087415518" LOG_EFFECT_SIZE="-0.2918016746751178" NO="3" P_CHI2="0.32342916404634536" P_Z="0.011814848262856123" STUDIES="2" TAU2="0.0" TOTAL_1="360" TOTAL_2="226" WEIGHT="45.85907691937633" Z="2.5176266547333217">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="1.213032215728307" CI_START="0.3232469579395344" EFFECT_SIZE="0.62618605351511" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="19" LOG_CI_END="0.083872335019289" LOG_CI_START="-0.4904655535513284" LOG_EFFECT_SIZE="-0.20329660926601975" ORDER="78546" O_E="-4.112781954887218" SE="0.3373689187647807" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="8.785972942330512" WEIGHT="28.697195197686515"/>
<DICH_DATA CI_END="0.8541760485434287" CI_START="0.15447643505417868" EFFECT_SIZE="0.36324932331341503" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" LOG_CI_END="-0.06845261053885893" LOG_CI_START="-0.8111377615885991" LOG_EFFECT_SIZE="-0.439795186063729" ORDER="78547" O_E="-5.3208556149732615" SE="0.4362569340774065" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="96" TOTAL_2="91" VAR="5.25430542628079" WEIGHT="17.161881721689813"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.75314702881812" CI_END="0.3404774044678066" CI_START="0.16978625996078542" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.24043374369198783" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="110" I2="64.56260873374957" I2_Q="72.43856745061798" ID="CMP-002.06" LOG_CI_END="-0.4679117044283183" LOG_CI_START="-0.7700974581713111" LOG_EFFECT_SIZE="-0.6190045812998147" METHOD="PETO" MODIFIED="2009-05-05 10:56:42 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.00612831171841155" P_Q="0.02656246515242966" P_Z="9.773126893603575E-16" Q="7.256516860713191" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="921" TOTAL_2="798" WEIGHT="100.0" Z="8.029674930637366">
<NAME>Restenosis/occlusion of the operated artery</NAME>
<GROUP_LABEL_1>Patch</GROUP_LABEL_1>
<GROUP_LABEL_2>No patch</GROUP_LABEL_2>
<GRAPH_LABEL_1>Patch better</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Patch worse</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.3583246168166645" CI_END="0.6643886114962256" CI_START="0.1719904628775128" DF="2.0" EFFECT_SIZE="0.33803624779272395" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="28" I2="15.194032842702612" ID="CMP-002.06.01" LOG_CI_END="-0.17757782054143828" LOG_CI_START="-0.7644956346884106" LOG_EFFECT_SIZE="-0.4710367276149245" NO="1" P_CHI2="0.3075363035699772" P_Z="0.0016553292729790232" STUDIES="3" TAU2="0.0" TOTAL_1="219" TOTAL_2="210" WEIGHT="26.50900269663283" Z="3.145977168413804">
<NAME>Venous patch</NAME>
<DICH_DATA CI_END="0.89348014820687" CI_START="0.15669608237103" EFFECT_SIZE="0.37417220487404435" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="-0.0489150924252538" LOG_CI_START="-0.8049418613866264" LOG_EFFECT_SIZE="-0.42692847690594005" ORDER="78548" O_E="-4.984496124031008" SE="0.44409386648077315" STUDY_ID="STD-Eikelboom-1988" TOTAL_1="67" TOTAL_2="62" VAR="5.0704960639384655" WEIGHT="15.976205056991702"/>
<DICH_DATA CI_END="7.513492438406338" CI_START="0.1420422603088586" EFFECT_SIZE="1.03306991475154" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8758418536705893" LOG_CI_START="-0.8475824254167875" LOG_EFFECT_SIZE="0.014129714126900993" ORDER="78549" O_E="0.031746031746031855" SE="1.0123479526236943" STUDY_ID="STD-Myers-1994" TOTAL_1="62" TOTAL_2="64" VAR="0.9757540942302845" WEIGHT="3.074422561037099"/>
<DICH_DATA CI_END="0.6133960654276451" CI_START="0.047999843295370825" EFFECT_SIZE="0.1715893790959219" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.2122590140864037" LOG_CI_START="-1.3187601804591385" LOG_EFFECT_SIZE="-0.765509597272771" ORDER="78550" O_E="-4.172413793103448" SE="0.6499642623964542" STUDY_ID="STD-Vleeschauwer-1987" TOTAL_1="90" TOTAL_2="84" VAR="2.367124191541861" WEIGHT="7.458375078604029"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.869528023796606" CI_END="0.9772414491041925" CI_START="0.2195152830344558" DF="2.0" EFFECT_SIZE="0.463162426469493" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="20" I2="65.9257100078324" ID="CMP-002.06.02" LOG_CI_END="-0.00999812097052883" LOG_CI_START="-0.6585352380347342" LOG_EFFECT_SIZE="-0.33426667950263156" MODIFIED="2009-05-05 10:56:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.053143351750422285" P_Z="0.043342406486095275" STUDIES="3" TAU2="0.0" TOTAL_1="329" TOTAL_2="349" WEIGHT="21.71092358840178" Z="2.0203952428279934">
<NAME>Synthetic patch</NAME>
<DICH_DATA CI_END="7.819001095483542" CI_START="0.4708530936242797" EFFECT_SIZE="1.918749815598703" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8931512739768315" LOG_CI_START="-0.3271145718099766" LOG_EFFECT_SIZE="0.2830183510834274" MODIFIED="2009-05-05 10:56:42 +0100" MODIFIED_BY="[Empty name]" ORDER="112" O_E="1.268370607028754" SE="0.7167901982285262" STUDY_ID="STD-Al_x002d_Rawi-2006" TOTAL_1="146" TOTAL_2="167" VAR="1.9463273442593432" WEIGHT="6.1325212302333645"/>
<DICH_DATA CI_END="1.3305982436266446" CI_START="0.013731616092905699" EFFECT_SIZE="0.13517124048915022" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.12404694584702139" LOG_CI_START="-1.8622783470365065" LOG_EFFECT_SIZE="-0.8691157005947427" ORDER="78551" O_E="-1.47" SE="1.1667773095085603" STUDY_ID="STD-Katz-1994" TOTAL_1="49" TOTAL_2="51" VAR="0.7345545454545456" WEIGHT="2.3144469290075307"/>
<DICH_DATA CI_END="0.7736187724311396" CI_START="0.11449742685419866" EFFECT_SIZE="0.29761948660910853" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.11147300032068731" LOG_CI_START="-0.9412042732854872" LOG_EFFECT_SIZE="-0.5263386368030873" MODIFIED="2009-05-05 10:36:53 +0100" MODIFIED_BY="[Empty name]" ORDER="104" O_E="-5.101886792452831" SE="0.48738825697556526" STUDY_ID="STD-Mannheim-2005" TOTAL_1="134" TOTAL_2="131" VAR="4.2096876921583215" WEIGHT="13.263955429160884"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.2687775274916575" CI_END="0.24878676440884354" CI_START="0.09459801875437278" DF="1.0" EFFECT_SIZE="0.15341034842991363" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="62" I2="76.57408957108144" ID="CMP-002.06.03" LOG_CI_END="-0.6041727280692554" LOG_CI_START="-1.0241179592964487" LOG_EFFECT_SIZE="-0.814145343682852" NO="3" P_CHI2="0.03881901538815313" P_Z="2.971823665527438E-14" STUDIES="2" TAU2="0.0" TOTAL_1="373" TOTAL_2="239" WEIGHT="51.78007371496539" Z="7.599541240824769">
<NAME>Synthetic or venous patch</NAME>
<DICH_DATA CI_END="0.19485605845886667" CI_START="0.06066064376393981" EFFECT_SIZE="0.10872025546060284" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="45" LOG_CI_END="-0.7102860865900473" LOG_CI_START="-1.2170929850302488" LOG_EFFECT_SIZE="-0.963689535810148" ORDER="78552" O_E="-25.037593984962406" SE="0.2977008808783821" STUDY_ID="STD-AbuRahma-1996" TOTAL_1="264" TOTAL_2="135" VAR="11.283394188421898" WEIGHT="35.55190991570887"/>
<DICH_DATA CI_END="0.7736357537697451" CI_START="0.13753136868392413" EFFECT_SIZE="0.32618887792009765" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" LOG_CI_END="-0.1114634674332055" LOG_CI_START="-0.8615982349784934" LOG_EFFECT_SIZE="-0.4865308512058495" ORDER="78553" O_E="-5.769953051643192" SE="0.4406328756830876" STUDY_ID="STD-Ranaboldo-1993" TOTAL_1="109" TOTAL_2="104" VAR="5.150462226514073" WEIGHT="16.22816379925652"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-07-20 13:43:42 +0100" MODIFIED_BY="Hazel Fraser">
<APPENDIX ID="APP-01" MODIFIED="2009-07-20 13:43:21 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2008-09-09 20:24:23 +0100" MODIFIED_BY="[Empty name]">MEDLINE search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-20 13:43:21 +0100" MODIFIED_BY="Hazel Fraser">
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE 1966 to 1995</HEADING>
<P>Term used "carotid endarterectomy"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (Ovid) 1994 to 2008 and Cochrane Central Register of Controlled Trials (lines 1 to 12)</HEADING>
<P>1 Endarterectomy, carotid/<BR/>2 exp carotid arteries/su (surgery)<BR/>3 exp carotid artery diseases/su<BR/>4 exp carotid arteries/<BR/>5 exp carotid artery diseases/<BR/>6 carotid.tw.<BR/>7 4 or 5 or 6<BR/>8 endarterectomy/<BR/>9 (endarterectom$ or surg$).tw.<BR/>10 8 or 9<BR/>11 7 and 10<BR/>12 1 or 2 or 3 or 11<BR/>13 randomized controlled trial.pt.<BR/>14 randomized controlled trials as topic/<BR/>15 controlled clinical trial.pt.<BR/>16 controlled clinical trials as topic/<BR/>17 random allocation/<BR/>18 clinical trial.pt.<BR/>19 exp clinical trials as topic/<BR/>20 (clin$ adj25 trial$).tw.<BR/>21 random$.tw.<BR/>22 research design/<BR/>23 intervention studies/<BR/>24 control$.tw.<BR/>25 patch$.tw.<BR/>26 or/13-25<BR/>27 12 and 26<BR/>28 limit 27 to humans</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-07-20 13:43:42 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<TITLE MODIFIED="2008-09-09 20:24:51 +0100" MODIFIED_BY="[Empty name]">EMBASE search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-20 13:43:42 +0100" MODIFIED_BY="Hazel Fraser">
<SUBSECTION>
<HEADING LEVEL="3">EMBASE 1980 to 1995</HEADING>
<P>Terms used "carotid endarterectomy" and "carotid surgery"</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE (Ovid) 1994 to 2008</HEADING>
<P>1 carotid endarterectomy/<BR/>2 carotid artery surgery/<BR/>3 exp carotid artery disease/su<BR/>4 exp carotid artery/<BR/>5 exp carotid artery disease/<BR/>6 4 or 5<BR/>7 artery surgery/ or endarterectomy/ or vascular surgery/ or surgery/<BR/>8 6 and 7<BR/>9 (carotid adj5 (endarterect$ or surgery)).tw.<BR/>10 1 or 2 or 3 or 8 or 9<BR/>11 Clinical trial/<BR/>12 randomized controlled trial/<BR/>13 controlled study/<BR/>14 randomization/<BR/>15 random$.tw.<BR/>16 Prospective study/<BR/>17 "Evaluation and follow up"/ or Follow up/<BR/>18 versus.tw.<BR/>19 prospective.tw.<BR/>20 types of study/<BR/>21 methodology/<BR/>22 comparative study/<BR/>23 ((intervention or experiment$) adj5 group$).tw.<BR/>24 Parallel design/<BR/>25 intermethod comparison/<BR/>26 (controls or control group$).tw.<BR/>27 (control$ adj trial$).tw.<BR/>28 patch$.tw.<BR/>29 or/11-28<BR/>30 10 and 29<BR/>31 limit 30 to humans</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>